Next Article in Journal
Osteosarcoma and Ewing Sarcoma of Bone: An Italian Mono-Institutional Epidemiological Study
Previous Article in Journal
The Crucial Role of Laboratory Medicine in Addressing Future Public Health Infectious Threats: Insights Gained from the COVID-19 Pandemic
Previous Article in Special Issue
Multitask Learning for Mental Health: Depression, Anxiety, Stress (DAS) Using Wearables
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Wearables in Chronomedicine and Interpretation of Circadian Health

1
Department of Biology, Tyumen Medical University, 625023 Tyumen, Russia
2
Laboratory for Chronobiology and Chronomedicine, Research Institute of Biomedicine and Biomedical Technologies, Tyumen Medical University, 625023 Tyumen, Russia
3
Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Sciences, 634009 Tomsk, Russia
4
Institute of Biology/Zoology, Martin Luther University, 06108 Halle-Wittenberg, Germany
5
Department Engineering and Architecture, Institute of Building Technology and Energy, Lucerne University of Applied Sciences and Arts, 6048 Horw, Switzerland
6
Tokyo Women’s Medical University, Tokyo 162-8666, Japan
7
Halberg Chronobiology Center, University of Minnesota, Minneapolis, MN 55455, USA
8
Department of Molecular Immunology and Biotechnology, Institute of Physiology of Komi Science Centre, Ural Branch of the Russian Academy of Sciences, 167982 Syktyvkar, Russia
*
Author to whom correspondence should be addressed.
Diagnostics 2025, 15(3), 327; https://doi.org/10.3390/diagnostics15030327
Submission received: 20 November 2024 / Revised: 14 January 2025 / Accepted: 26 January 2025 / Published: 30 January 2025

Abstract

:
Wearable devices have gained increasing attention for use in multifunctional applications related to health monitoring, particularly in research of the circadian rhythms of cognitive functions and metabolic processes. In this comprehensive review, we encompass how wearables can be used to study circadian rhythms in health and disease. We highlight the importance of these rhythms as markers of health and well-being and as potential predictors for health outcomes. We focus on the use of wearable technologies in sleep research, circadian medicine, and chronomedicine beyond the circadian domain and emphasize actigraphy as a validated tool for monitoring sleep, activity, and light exposure. We discuss various mathematical methods currently used to analyze actigraphic data, such as parametric and non-parametric approaches, linear, non-linear, and neural network-based methods applied to quantify circadian and non-circadian variability. We also introduce novel actigraphy-derived markers, which can be used as personalized proxies of health status, assisting in discriminating between health and disease, offering insights into neurobehavioral and metabolic status. We discuss how lifestyle factors such as physical activity and light exposure can modulate brain functions and metabolic health. We emphasize the importance of establishing reference standards for actigraphic measures to further refine data interpretation and improve clinical and research outcomes. The review calls for further research to refine existing tools and methods, deepen our understanding of circadian health, and develop personalized healthcare strategies.

1. Introduction

Rhythms are recognized as hallmarks of health [1]. These oscillations can be measured and quantified utilizing diverse mathematical methods and modeling approaches. When such oscillations deviate from their optimal ranges, they can be harnessed as early warning signs for the detection of impending risk and for the implementation of countermeasures to improve health outcomes [2,3,4,5,6,7], epitomizing a pivotal element in the burgeoning domain of circadian medicine [4,7,8,9]. Perturbations in circadian rhythms, both at the molecular and systemic levels, are correlated with the processes of aging and the pathogenesis of diseases [1,2,3,7,10,11,12]. The meticulous assessment of the normal range of physiological variables necessitates the employment of sophisticated monitoring techniques that involve both data collection and data analysis for a chronobiological interpretation of the results. In the field of circadian medicine research, and chronomedicine more generally (also concerned with time structures other than circadian rhythms), various wearable technologies are utilized to monitor and study sleep patterns, activity levels, and other physiological markers that align with our biological clocks.
In the investigation of the optimal characteristics of rhythmic structures, quantitative measures are assessed, alongside deviations from the optimum that may be associated with health risks. These deviations typically encompass both parametric and non-parametric measures. Parametric measures are useful for many circadian functions, which can be described using sinusoidal curves or multi-component models. To accurately characterize the parameters of biological rhythms—namely amplitude, phase, and period length—data collection must occur at suitable intervals across one or, preferably, multiple cycles. Ideally, this collection should be sampled at regular, equidistant intervals; however, it is also feasible with irregular intervals [13,14]. Assessing the intrinsic period in real-life scenarios poses challenges, as its determination necessitates specific, controlled conditions within a laboratory setting, such as the “constant routine” or “forced desynchrony protocol” [15]. Conversely, amplitude and phase evaluations are more feasible in real-life circumstances. By collecting data over several cycles, researchers can introduce a “regularity” domain to measure the stability of phase and amplitude across cycles. Non-parametric measures can be preferred for functions with abrupt transition points, such as wake–sleep–wake states, and include characteristics that eschew the sinusoidal rhythm model yet still facilitate the characterization of amplitude, timing, stability, and fragmentation. Longitudinal and dense data sampling enables a thorough assessment of physiological variability and any divergence from the normal range.
Monitoring and wearable technologies offer excellent means to achieve this objective. Physical activity, temperature, heart rate, and light exposure are among the most accessible and trackable variables by wearables. Moreover, these variables hold greater physiological significance and, in addition to mere step counts, allow for the sampling of quantified values. The selection of the most appropriate method for data analysis is contingent upon the specific physiological variable under consideration. For instance, physical activity may be best characterized through non-parametric approaches due to its non-sinusoidal patterns, whereas temperature typically exhibits a more sinusoidal nature. While wearable technologies offer significant advancements in health monitoring, they are not without limitations. For instance, measurements of wrist temperature, though less intrusive, are often marred by substantial noise in comparison to core body temperature. Their timing may be nearly, though not precisely, in antiphase with those of core temperature. They reflect the work of a special mechanism that ensures a decrease in basal temperature in the evening/night due to heat dissipation, which is necessary for falling asleep and maintaining sleep [16,17]. On the other hand, professional-grade wearables, such as actigraphs, facilitate the assessment of phase alignment among various physiological variables. This is particularly pertinent when incorporating measurements of light exposure, which serves as the principal circadian synchronizer.
In the fields of circadian medicine research and chronomedicine, various wearable technologies are utilized to monitor and study sleep patterns, activity levels, and other physiological markers that align with our biological clocks. Some types of wearables already in use or still in development in this area are summarized in Table 1. Overall, innovative wearables and analytical tools work together to derive refined reference ranges and identify new biomarkers to assess health quality and disease risk [18,19,20,21,22,23,24,25]. It has been emphasized that devices should be evaluated for their intended use in relevant populations, such as patients with mild cognitive impairment at risk of developing Alzheimer’s disease for their intended use [26]. The design of new devices should also keep these specific patient groups in mind. Analysis of electrocardiogram time series using machine learning (ML) algorithms made it possible to reliably identify sleep phases, rapid eye movement/non-rapid eye movement (REM/NREM) [27,28], indicating great prospects for using ML in somnology and chronobiology. However, despite the variety of affordable multisensory wearable devices on the market, their wide public use and Bluetooth compatibility, actigraphy remains a tool best validated scientifically for research in chronomedicine. It provides objective, real-life insights into an individual’s sleep, activity, and light exposure patterns, providing full access to raw data, which is highly important in research [20]. Earlier actigraphs’ embedded accelerometers allowed the device to record body movements, providing a representation of activity levels over extended durations [29,30,31]. It was commonly used to assess sleep quality but also had applications in various medical fields [32,33], including psychiatry, neurology, oncology [34], and geriatrics. Actigraphy has proven to be a valuable tool in diagnosing and managing various conditions, including depression, narcolepsy [35], Alzheimer’s disease, Parkinson’s disease, and dementia [36,37,38]. Actigraphy also serves as a quantitative measure of physical activity throughout the day. Monitoring movement enables researchers to evaluate an individual’s average activity, periods of sedentary behavior, and compliance with study protocols. To estimate measures of physical activity, including energy expenditure, wrist- and hip-worn devices produce comparable results [39]. Advanced actigraphy units are now equipped with sensors for wrist temperature and ambient light [40], allowing for a more comprehensive examination of rhythms and their perturbations. Through the analysis of activity patterns and wrist temperature, researchers can deduce information about the internal circadian clock and its influence on health.

2. Actigraphy Features: Beyond Sleep

Considering the thorough exploration of implications, constraints, and viewpoints of actigraphy within the realm of sleep medicine, as detailed in prior literature [24,41,42,43,44,45], this review aims to encompass the infrequently employed, yet increasingly acknowledged applications of actigraphy for the quantification of physical activity, assessment of metabolic health, and the prognostication of lifespan. Subsequently, this review will also deliberate on the eminent roles of commercially available wearable devices in the sphere of circadian medicine and chronomedicine more broadly, including rhythms with periods outside the circadian domain [1,2,7]. These applications do not solely revolve around sleep, as they also involve quantifying circadian (about 24 h–20 to 28 h range) and extra-circadian (ultradian, with periods less than 20 h, and infradian, with periods longer than 28 h) variability, based on dense (usually every minute) and longitudinal (usually weeklong) sampling. To examine time structures of the rest-activity cycle as it changes over time, actigraphy can be empowered with several mathematical tools. In a parametric approach, the period, τ, is the duration of one cycle; the MESOR (Midline Estimating Statistics Of Rhythm) is a rhythm-adjusted mean; the amplitude is a measure of half the extent of predictable change within a cycle; and the acrophase is a measure of the timing of overall high values recurring in each cycle [13]. It extends from circadian to both ultradian and infradian rhythms in a comprehensive spectral analysis [11,46,47]. Acigraphy also includes a non-parametric approach used to derive the following indices: M10, M10 Onset, L5, L5 Onset, inter-daily stability (IS), intra-daily variability (IV), relative amplitude, circadian function index, etc., as features of physical activity [48,49,50,51,52]. The same parametric and non-parametric approaches can also be applied to the other variables (wrist temperature, ambient light measured at different wavelengths, e.g., red, green, blue, ultraviolet A, ultraviolet B, infrared, or even spectrally resolved). Furthermore, they can be used to calculate novel, more sensitive health markers such as indices of daytime light deficit and nocturnal light excess [53], scalar regression markers [54], phase angles between activity and light [55,56], or integrated variables such as TAP, which incorporates measures of three variables (temperature, activity, and position) [50]. A personalized approach to searching for circadian markers of health and disease, quantified by wearable technologies, can be most fruitful, as certain genetic-, gender-, or geographically related phenotypes may be particularly vulnerable to circadian disruption [53].
Actigraphy acquired a growing interest in studies of metabolic health and circadian syndrome, which can be a more precise definition of metabolic syndrome [57,58]. By continuously tracking physical activity and sleep duration, actigraphy provides valuable data that can be correlated to various metabolic endpoints, such as glucose concentrations, insulin sensitivity, and lipid profiles [56,59,60,61,62,63,64]. This approach offers a holistic view of daily habits and their putative effect on metabolic health. Furthermore, integrating actigraphy data with biobank big data enhances the depth of analysis, allowing researchers to explore correlations between activity patterns, genetic factors, and metabolic outcomes on a large scale. Biobanks, repositories of biological samples and associated health data, play a crucial role in advancing our understanding of complex diseases like diabetes, obesity, and cardiovascular disorders, in addition to neurodegenerative diseases and mood disorders that were extensively investigated previously. Actigraphy is promising in identifying early markers to predict cardio-metabolic risks and providing personalized preventive strategies. Furthermore, actigraphy can be used to evaluate the effectiveness of strategies for improving sleep or optimizing the amount and timing of physical activity.
Several important topics, including the comparative analysis of circuit design, power supply, device longevity, measurement accuracy, noise characteristics, calibration methods, and the advantages and limitations of device types such as GPS, accelerometers, and light sensors, as well as the performance and reliability of wearable devices, warrant specific attention in a separate review, as they are outside our scope herein.

3. Overview of Actigraphic Health Markers

Actigraphy and other wearable technologies provide a non-invasive and efficient method for continually monitoring physiological functions in real-world environments. These tools have a wide range of applications in research, clinical practice, and personal health monitoring, making them an invaluable resource for quantifying and comprehending various aspects of health and well-being. They are particularly useful when used in conjunction with the central synchronizer of the circadian clock, light, to measure circadian light hygiene and its influence on health and well-being. By combining objective data on light exposure with information on sleep patterns and circadian rhythms, actigraphy can help to pinpoint strategies for promoting optimal circadian alignment and enhancing overall health outcomes. Most common forms of circadian disruptions that are revealed by actigraphy are summarized in Table 2 and schematized in Figure 1.
A decline in circadian robustness with age and disease is considered a general biological feature and may serve as an unspecific marker of biological age to predict healthy aging and longevity [1,2,10,11,65,66,67,68]. The following parametric/non-parametric indices are commonly used to characterize circadian and 24 h variability of physiological variables such as activity, temperature, and light exposure.
Parametric [13]:
y(t) = M + ΣiAicos (2πt/τi + φi), i = 1, …, k
(usually, τ1 = 24 h accounts for most of the variance and its parameters (A1, φ1) are useful biomarkers)
y—related data; t—time
acrophase (φi), moment in time when component with period τi reaches its peak in relation to a given reference time;
MESOR—Midline Estimating Statistics Of Rhythm (a rhythm-adjusted mean);
Ai—Amplitude of component with period τi.
Note that a multi-component cosinor is usually most appropriate (e.g., blood pressure and heart rate are usually fitted with a 2-component model, including the 12 h harmonic term). While composite models yield a better approximation of the rhythm’s waveform, the fundamental component, with a period of 24 h, often accounts for most of the variance, and its parameters can serve as valuable biomarkers.
Non-parametric [48]:
M10—the average of 10 h of highest values.
M10 onset—the start of the M10 period.
L5—the average of 5 h of lowest values.
L5 onset—the start of the L5 period.
RA (relative amplitude); RA = (M10 − L5)/(M10 + L5)
IV (intra-daily variability) estimates how variable activity is within a day and can range from 0 to ∞, where higher values represent higher fragmentation. IV is calculated by the following formula, where N—total number of measurements in the full time series, Xi—individual values at time i, Xm—mean of all Xi values:
I V = N i = 2 N X i X i 1 2 ( N 1 ) i = 1 N X i X ¯ 2
IS (inter-daily stability) measures how constant the rest-activity pattern is between days and ranges from 0 to 1. Values closer to 1 mean more constant rest-activity patterns. Assuming that measurements are binned over hourly equal intervals per day over the whole time series, IS is calculated by the following formula, where N—total number of measurements in the overall time series, p—number of data points per 24 h, Xi—individual values at time i, Xm—mean of the overall time series, Xmh—hourly means:
I S = N h = 1 p X ¯ h X ¯ 2 p i = 1 N X i X ¯ 2
Note that additional measures of activity-rest patterns were recently proposed [52]: the activity balance index (ABI), transition probability (TP), self-similarity parameter (α), which may have merits beyond IV and IS, being independent of differentiation between rest/activity states that currently lack standardization. However, unlike IV or IS, ABI and α are sensitive to extreme values that could be observed in the data.
The activity balance index (ABI) estimates how balanced activity is during the observation span. It ranges from 0 to 1, with values closer to 1 meaning a more balanced activity distribution.
The transition probability (TP) estimates transitions from rest to activity state (A → R, AR) or vice versa (R → A) at a given time point t. TP ranges from 0 to 1. Higher values indicate higher transitions from activity to rest or vice versa.
The self-similarity parameter (α) approaches self-similarity of the acceleration signal during the observation span. It ranges from 0 to 2. If the values fall between 0 and 1, it indicates that the motion is steady and predictable. When the values are between 1 and 2, it suggests that the motion is more erratic and unpredictable. There are some key points to note: a value of 0.5 represents random noise, 1 indicates a pattern called fractal noise, and 1.5 signifies a random walk, which is a type of movement that seems to take random steps.
The Sleep Regularity Index (SRI) is another novel metric [94,116], which can be applied to evaluate an individual’s sleep patterns for their consistency. The SRI is calculated by determining the percentage probability that an individual’s sleep state (asleep or awake) remains the same when comparing two time points that are 24 h apart. This probability is then averaged over the entire observational period, providing an overall indication of sleep regularity. It can range from 0 to 1. A higher SRI indicates a more consistent sleep pattern, whereas lower values mean greater variability in sleep-wake conditions. SRI can be re-scaled as y = 200 (x − 1/2) to scale in the range from −100 to 100 [94]. After such re-scaling, regularity of sleep patterns gauged by SRI typically ranges between an SRI of 0 (random or irregular sleep) and 100 (structured or periodic sleep).
Different approaches for the precise assessment of circadian phase in field studies can be used with relative merits that may depend on research purposes and conditions [117,118] and also on the extent of alignment between activity and light exposure [119]. For certain purposes, such as delayed sleep–wake phase disorder, light-based methods incorporating multiple linear regressions of light exposure for phase assessment were recommended [88], while activity-based models can be useful in older adults (aged 58 to 86 years) [120] who tend to advance their sleep phase. Activity-based phase modeling has been shown to outperform light-based modeling in predicting the dim light melatonin onset (DLMO) in shift workers [121]. Our own data suggest that the same may hold true for cosinor-based models. However, their effectiveness may depend on ambient light conditions and the circadian light hygiene index [122], both of which can vary significantly with the seasons [123]. Furthermore, in view of substantial individual differences in light sensitivity [124], predictions can vary widely among individuals, influenced not only by genetic factors but also by other co-factors, such as a history of COVID-19. This history can affect circadian patterns and light sensitivity related to actigraphy-based measures [125] as well as blood pressure [126].
Estimates of amplitude and phase as proxies of circadian rhythm may require different methods with distinct inherent strengths in modeling biological oscillations:
Cosinor Analysis was developed specifically for the purpose of modeling cyclic data and is particularly useful for estimating rhythm parameters like amplitude and acrophase [13,125,127,128,129,130,131]. While the single-component model assumes the pattern to be sinusoidal, consideration of additional harmonic terms with periods of e.g., 12, 8, and 6 h can approximate the waveform more precisely, including phase estimation.
Non-parametric Actigraphy Indices [48,49,50,51,52] capture informative features of the circadian rhythms of activity and light exposure, such as their extent of irregularity. However, their precision in quantifying amplitude may be more subjective in interpretation, leading to greater variability in results.
Moving Linear Regression Models used for sleep/wake scoring over short (e.g., 1-min) intervals are widely applied to characterize basic sleep parameters [33,132,133], thereby capturing important features of the circadian rhythm other than the amplitude and phase.
Artificial Neural Networks (ANNs) are capable of handling complex correlations and can therefore determine amplitude and phase for various types of data [134,135,136]. Nevertheless, the efficiency of the networks directly depends on the availability of sufficient data for training. These techniques may not be as easy to use for the purpose of estimating amplitude and phase as is the case with cosinor. Results from a study using actigraphy data of blue light and temperature indicated that the ANN model was capable of predicting circadian timing within ±2 h for most individuals following diurnal schedules. This method, however, did not extend to night shift scenarios [126].
Limit-Cycle Oscillator Modeling effectively represents biological oscillations and can provide information on feedback mechanisms, allowing dynamic estimations of amplitude and phase. On the other hand, their complexity and need for extensive computational resources can limit their practical applications. Limit-cycle oscillator modeling is most effective for estimating parameters with non-sinusoidal patterns and when phase stability is low (shift work) [135,137].
Approximation-Based Least-Squares Methods [33,138] offer significant versatility, being capable of accommodating a wide range of models, including non-linear ones, which makes it particularly useful for estimating amplitude and phase. These methods efficiently reduce residuals to enhance model fit; however, they can require substantial computational resources, especially when working with highly complex models. Additionally, their implementation may be less convenient and more challenging to interpret, potentially complicating their practical application.
Furthermore, several methods can improve cosine decomposition, particularly in investigations of ultradian oscillations and their interpretation:
Fourier transformation decomposes a signal into constituent frequencies, allowing for the analysis of periodic components. It is effective for analyzing periodic signals and identifying dominant frequencies in spectra [139]. Fourier transformation can utilize walking accelerometer data to predict somatic health [140] and can outperform a non-parametric approach in identifying depression [141]. However, like other methods, it can be sensitive to noise, outliers, and non-stationarities of the signal (when mean, variance, and autocorrelation structure are not consistent over time).
Wavelet transformation [142,143] allows a thorough analysis of non-stationary signals and detects transient features in circadian and extra-circadian signals. However, it is more complex to implement and interpret than traditional methods and requires careful and subjective selection of parameters.
Hilbert transformation [144,145,146] is useful for extracting instantaneous frequency and amplitude of oscillations, providing insights into complex rhythmic patterns and their phase relationship [147]. It can be used for analyzing non-linear and non-stationary signals. However, it is also sensitive to noise and requires continuous data; furthermore, interpretation may be challenging without a solid understanding of the underlying mathematics.
The choice between different methods of actigraphy/wearables data analyses largely depends on the specific research goals, the sources of the data, and the expected rhythms to be analyzed. Table 3 provides a brief comparison of the relative merits of the different methods used to analyze data from wearables.

4. Interpretation of Deviant Parameters

4.1. Faded Circadian Oscillation (Amplitude Decrease)

Examples are reduced relative amplitude of activity with a non-parametric approach: lower daytime physical activity or light exposure (M10) that can be accompanied by higher nocturnal activity or light exposure (L5) is indicative of poorer sleep or light hygiene. Reduced circadian amplitude of activity by cosinor or other non-linear approximations similarly relates to lower daytime but higher evening physical activity, Figure 2. In addition, the regularity of physical activity or light exposure patterns can be assessed by comparing the ratio of the amplitude assessed by separate 24 h cycles (A24) to the amplitude approximated over the entire monitoring period, e.g., week (Aw). When activity or light exposure occurs irregularly, Aw/A24 is reduced. The normalized amplitude (NA) can serve as a valuable metric to quantify both physical activity (PA) and light exposure (LE), Figure 3. It is particularly advantageous for LE, which often assumes extremely low or null values during the nighttime. Applying a log transformation can effectively normalize these values, albeit at the cost of reducing daytime variations when LE is generally high.
Mean values for physical activity, ambient light, and wrist temperature (24 h, diurnal, such as M10, nocturnal, such as L5) can be indicative—and serve as proxies—of health and as mortality and morbidity risk factors for certain diseases (Figure 1, Table 2). Examples are low 24 h physical activity, increased or decreased temperature, and low sunlight exposure. Mean values, however, can be restricted to the daytime or to the nighttime, and this information needs to be specified as it affects its interpretation. Indeed, health hazards stem from lowered diurnal, but elevated nocturnal activity, and from low daylight exposure but light-at-night. Therefore, deviations in circadian endpoints other than the mean value also deserve consideration. Changes in the 24 h amplitude and in circadian robustness are cases in point. They can be estimated by absolute measures of A or RA or their normalized values (relative to the individual mean), NA/NRA. The latter may be preferred when inter-individual variability of averages (or MESORs) is high. Alternatively, a measure of circadian robustness can consider the spectral domain of ultradian and infradian frequencies to incorporate the analysis of the relative amplitudes among particular ultradian and infradian frequencies to the circadian, which adds valuable new information. The circadian rhythm is usually the dominant component with the highest power or amplitude in weeklong records of physiological variables that can be recorded with wearable monitoring devices. The relative decrease in circadian prominence to extra-circadian domains is defined as extra-circadian dissemination, ECD [2,10,11]. Another approach includes integrative values for three related actigraphy variables (temperature, position, and activity, TAP), used to estimate the Circadian Function Index [50]. A decrease in circadian robustness, as gauged by either of these methods, is a feature associated with aging, diseases, and health risks.
To ensure comparability among the aforementioned quantitative indices of circadian health, it is imperative to standardize the following essential sampling attributes across various studies: total duration of recording, frequency of observations within the time series, and the number, timing, and extent of interruptions in the dataset. When data are non-equidistant, a measure of the distribution in time of the observations can help determine the frequency region within which reliable results can be anticipated.

4.2. Phase Deviations

Phase deviations—both too late and too early maximal values—may serve as health risk predictors. However, stronger evidence has accumulated to explain a phase delay since it is closely linked to and can be driven by poor circadian light hygiene. Phase relationship—phase lag between light and activity (or sleep and melatonin) that can be predicted by wrist temperature (wT) provides more specific information, which, however, can strongly depend on the power of light signaling that varies profoundly depending on the local light environment and seasonal photoperiodism.
A diminution in circadian robustness may stem from a true reduction in amplitude or a deterioration of phase stability. For example, irregular circadian timing (e.g., irregular sleep–wake patterns), which has been associated with a higher mortality risk [149], leads to a reduced amplitude when data are analyzed over several days but not when data are analyzed over a single day (cycle). Indeed, the most common health risks related to circadian disruption are a reduced amplitude, a deviation from sinusoidality, a delayed phase, a compromised phase alignment, and an increased day-to-day instability and fragmentation of the circadian activity rhythm (Table 2).
Phase instability usually means misalignment between circadian oscillations of the distinct circadian functions. It can be caused by a weakened light signaling due to poor circadian light hygiene [4,5,6,150,151,152,153] or by a compromised light perception due to issues with retinal ganglion cells [69,92,103,154,155]. As far as measurable overt rhythms are concerned, it can also be due to the uncoupling between peripheral oscillations or the perception of central clock signaling to peripheral clocks [7,153,156,157]. Phase scattering may occur without changes in mean phase position, or it can be accompanied by a phase delay or phase advance. Accumulating evidence indicates that a phase delay, which is usually linked to a late chronotype, is a common health risk factor (Table 2). A phase delay is associated with evening light exposure and lack of diurnal light [153], or light perception [154,155], but it can also be attributed to certain clock genes or clock-controlled genes related to chronotype [158].

4.3. Fragmentation and Ultradian/Infradian Modifications

Modifications of circadian oscillations may occur within a cycle (fragmentation, or prominence in ultradian harmonics) or between consecutive cycles (scattered, unstable circadian parameters such as the 24 h phase, or higher prominence of infradian components). They can be accompanied by a greater deviation of the best-fitted model from an ideal sine curve, i.e., a reduction in the percentage of rhythm. In actigraphy, the most commonly used indices are the non-parametric indices IV and IS [48], which can be used to predict numerous health hazards (Table 2). Quantified approaches to estimate the loss of regularity can be applied to characterize sleep and its stages [46,47].
In addition to deviations in characteristics of circadian rhythms, modifications can be observed in the relationships between circadian and extra-circadian components, such as regular oscillations in the ultradian (periods shorter than 20 h) or infradian (periods longer than 28 h) domains. Regular movement patterns during sleep (locomotor inactivity during sleep) were first described by pioneers in sleep research [159]. They were observed using early accelerometer-based techniques [30] and again recently in modern actigraphy studies [46]. Regular ultradian oscillations with a period of about 110 min characterize activity during sleep. Such oscillations gradually fade across the night. The amplitude of this ultradian rhythm does not depend on sex but is modified by sleep duration and shift work, and gradually declines with age [46]. Ultradian sleep cycles may belong to endogenous biological rhythms and are influenced by factors such as age, gender, and the balance of sleep needs; however, in individuals who are healthy and sleep well, these cycles do not directly change in response to moderate environmental stimuli [47]. Infradian rhythms can be related to geophysical and social cycles and include yearly, monthly, and weekly fluctuations [160,161,162,163]. There is indirect evidence that circaseptan (about-weekly) rhythms [164,165] and circa-lunar cycles [166,167,168] may also be partly endogenous.
In addition to non-parametric indices, inter-daily stability and intra-daily variability can also be assessed by using an ECD model, such as the computation of ultradian-to-circadian and/or infradian-to-circadian rhythm amplitude ratios [2,10,11]. The relative prominence of circadian, ultradian, and infradian rhythms changes with age and disease for different physiological variables such as heart rate, blood pressure, and temperature [11,12,66]. Due to the fact that changes in ultradian and infradian components are influenced by distinct physiological mechanisms [2,11], it is essential to utilize these methods to examine variability and identify disease-specific predictors. As modern wearables acquire a wider range of functions, which can be naturally more sinusoidal than physical activity, characterization of spectral domains (ultradian, circadian, infradian) and their interplay can become a fruitful approach.
Increased sleep irregularity gauged by SRI was linked to several health hazards: a higher 10-year risk of cardiovascular disease, as well as higher rates of obesity, hypertension, elevated fasting glucose levels, hemoglobin A1C, and diabetes [169]. Additionally, higher SRI was associated with higher levels of perceived stress and depression [169,170] and higher body mass index [171]. SRI also showed a U-shaped relationship with the risk of developing dementia. Irregular sleep patterns could be a new risk factor for dementia, and gray matter and hippocampal volume [172].

4.4. Misalignment (Intrinsic Desynchrony)

Increased intrinsic desynchrony or circadian misalignment between variables has been shown to be a significant predictor of health risks (Table 2). Examples include the light-activity phase lag [56] and the surrogate index of phase of entrainment, specifically the sleep–temperature phase relationship [173,174]. The temperature phase can serve as a substitute for the golden standard of the melatonin phase, as the phases of temperature and melatonin exhibit a relatively close relationship [175,176,177]. Misalignment between the central clock phase and phases of local or peripheral oscillations [103] can be assessed by the integration of novel sensors into wearables.

4.5. Social Jet Lag: Objective Characterization by Wearables

Social jet lag (SJL) refers to the regular misalignment between the personal endogenous circadian clock and social obligations, such as work or school schedules [178,179]. It can occur when individuals stay up later and sleep in on weekends or holidays, causing their internal body clock to be out of sync with their typical weekday routine. It can lead to fatigue, difficulty concentrating, and overall reduced well-being [179]. Greater SJL is associated with an increased risk of cardio-metabolic [107,108,109,110,111] and mood [110,112,113,114] disorders. As actigraphy provides objective measures of activity and temperature, these data can be used to assess circadian health and phase changes on a daily basis in weeklong records [180]. The most abundant actigraphy data that were collected and made available for large database analysis include physical activity. When adopting sampling frameworks that account for weekly patterns, it becomes crucial to calibrate or rectify the data to reflect the actual number of workdays versus days off, including instances of shift work or sporadic commitments that necessitate awakening outside the regular schedule. Furthermore, incorporating details regarding the timing and length of daytime naps enriches the dataset, particularly for the accurate calculation of sleep-related metrics. In older adults, SJL very often approaches zero, which is due to the fact that upon retirement, the main external factor (work schedule) ceases to affect them [111]. Therefore, studying the acute effects of SJL on the health of older people is usually ineffective. The most promising in this case is the study of the chronic effects of SJL on human health.

4.6. Composite Markers

Searching for markers that are specific to the risks of certain pathologies can yield positive results when analytical focus is placed on timeframes that correlate with phases of increased sensitivity and physiological response (Table 2). Examples are: (1) areas above (nocturnal excess index, NEI) or under (Daylight Deficit Index, DDI) the curve of optimal 24 h exposure to light [53], where thresholds are based on existing consensus recommendations [181]; (2) MLiT500, the average clock time of all aggregated data above 500 lux [104]; and (3) FOSR (function-on-scalar regression), a method seeking time-of-day differences in a comparison of models fitted to groups defined by the presence or absence of a given risk factor or pathology [54]. NEI and MLiT500 were predictive of body mass index; NEI was also linked to metabolic issues within the 9:30 to 00:30 timeframe, specifically in carriers of common melatonin receptor gene polymorphism, MTNR1b rs10830963; DDI was linked to elevated cortisol concentrations [53]. The FOSR method detected daytime and evening timeframes of higher activity and variability in activity, which were predictive of Alzheimer’s disease with PET-confirmed beta-amyloid Aβ deposition [54]. Novel wearable-based digital markers, encompassing circadian amplitude, phase, and physical activity for biological age evaluation [131], can be useful for further advancement in preventive strategies of circadian medicine.
In relation to blood pressure and heart rate, chronobiological reference values were derived to assess the percentage time elevation/reduction, the amount of excess/deficit, and their timing along the 24 h scale. Similar reference values, qualified by gender and age, derived for all circadian parameters, identified new risk factors related to the amplitude and phase. These abnormal features of the circadian variation in blood pressure and heart rate, known as vascular variability disorders (VVDs), were shown to predict adverse cardiovascular outcomes in several outcome studies [84,85,182,183].

5. Circadian Health Markers from Actigraphy

As major markers of circadian disruption described in Table 2 are unspecific and can be related to frailty, aging, or different diseases, further study should seek more specific manifestations of compromised circadian robustness. They can be successful in tracking specific variables and specific indices, also seeking polymorphic gene variants in core-clock or clock-controlled genes [7]. Several genes (e.g., CLOCK, BMAL1, PER1,2,3, and MTNR1B) have SNPs that were consistently linked to compromised circadian health related to cardio-metabolic [5,53,184] or neurodegenerative [5,120,121,184,185,186] diseases.
Establishing reference standards for actigraphy-derived measures is a pressing need that has begun to be addressed. These standards are crucial for providing benchmarks or normal ranges against which individuals’ sleep–wake patterns, activity patterns, and circadian and light hygiene patterns can be compared. By defining these norms, we can better understand deviations that may indicate underlying health issues, facilitating more accurate diagnoses and personalized treatment strategies. Developing reference standards for actigraphy-based parametric and non-parametric indices is a significant step forward in the field of circadian medicine and sleep research. Establishing reference standards for different indices of the distinct measurable variables will allow better interpretation of wearable-collected data and facilitate comparisons across studies and populations. It will enable clinicians and researchers to identify deviations from normal ranges, which may indicate sleep disorders, circadian rhythm disturbances, or other health issues. When light exposure is tracked, drastic seasonal changes, especially at higher latitudes, must be considered as well [53]. Certain individual phenotypic traits, such as disease conditions [26] or skin color [20], that may have an effect on data quality should also be considered.
Recent studies have delved into deviations from optimal circadian health using actigraphy, with a significant portion of them utilizing extensive databases like the UK Biobank [36,70,71,72,73] and NHANES in the USA [68,74,75,76]. While many studies focused on disruptions in the circadian rhythm of physical activity, some also explored deviations in temperature and light exposure rhythms. The following sections outline key findings that highlight the associations between actigraphy or wearable-based circadian measures of health and various health outcomes, including morbidities, frailty, mortality, and longevity. Table 2 provides a comprehensive summary of these studies, detailing the specific aspects of circadian health that were found to be altered in relation to health status. These aspects, however, can strongly depend on the power of light signaling that varies profoundly depending on the local light environment and seasonal photoperiodism.
The circadian rhythm of physical activity plays a crucial role in maintaining bodily [89,187,188,189] and mental [90,190,191] health. A recent retrospective assessment of actigraphy data from a large UK biobank cohort (over 100,000 participants, 40–69 years of age) revealed that a large amplitude of the circadian activity rhythm is associated with lower risks of numerous health issues, including cardiovascular, metabolic, respiratory, infectious, cancer, and all-cause mortality [71]. Similar results were obtained in a prospective 16-year-long survey of over 1000 adults [72]. Moreover, 73 out of 423 (17%) disease phenotypes were significantly associated with a reduced circadian amplitude of the wrist temperature rhythm in actigraphy records from over 100,000 participants, the strongest associations found in relation to type 2 diabetes, non-alcoholic fatty liver disease, hypertension, and pneumonia [73]. A smaller amplitude and reduced circadian robustness were associated with an increased susceptibility to mood disorders such as major depressive disorder and bipolar disorder, mood instability, and neuroticism [70]. Similar markers predicted cognitive deficits in Alzheimer’s and Parkinson’s diseases [36,38]. A larger RA and lesser fragmentation (higher IV, lower IS) of wrist temperature were associated with better sleep quality in Japanese adults [77].
In addition to amplitude and fragmentation, a deviant circadian phase or deviant non-parametric estimates of indices such as M10 or L5 Onset were also indicative of elevated morbidity/mortality risks. Besides a smaller amplitude, a delayed activity phase was related to higher mortality from cancer and stroke [187] and higher risks of dementia or mild cognitive impairment in community-dwelling elderly women [190]. Earlier or later L5 onset vs. intermediate values in the range of 3:00–3:29 from 7-day actigraphy records from 88,282 adults in the UK Biobank was linked to a 20% higher risk of all-cause mortality [91]. Another study including records from 103,712 UK Biobank participants found a relationship between earlier or later sleep onset (compared to optimal onset between 22:00 and 23:00) and the risk of developing cardiovascular diseases, particularly in women [93].
Given that L5 onset and sleep mid-time are markers of chronotype, both studies suggest that the relationship between chronotype and health hazards is non-linear, as opposed to linear. Since chronotype changes with age (also in the 40–70 age range) sex-dependently [192,193], as shown in the UK Biobank database, a more sophisticated analysis is warranted that adjusts some metrics from the UK Biobank or other large databases for age and gender. Such adjustments in the estimation of circadian timing can be helpful to address the question of whether the optimal circadian phase position can be assessed considering the circadian resonance concept, which links longevity to an intermediate morning chronotype. This concept is expected to be indicative of the precise intrinsic circadian clock phenotype in humans [158,194].
As was first revealed by self-measurements for body temperature, amplitude and phase disruptions are present in prediabetes and further worsen in diabetes [78]. Actigraphy validates and further develops approaches to quantify metabolic risks related to obesity and diabetes [53,56,61,62,63,79,195,196]. Again, a smaller circadian amplitude and a delayed phase [62], a weaker coupling between light and activity [56], and a reduced quality of circadian light hygiene, such as excessive evening light [53,63], are linked to greater metabolic risks. In a study of 84,790 UK Biobank participants wearing light sensors for a week, the circadian amplitude and phase were modeled from light data, showing a relationship between exposure to light at night and type 2 diabetes risk [79]. A higher risk of type 2 diabetes was associated with brighter night light exposure, a smaller circadian amplitude, and a displaced position of the circadian phase, independently of genetic risk factors [79]. In this study, an association was also found between a higher type 2 diabetes risk and lower daytime light levels, which became non-significant when physical activity was included as a co-factor in the model.
Given the interplay between physical activity and daylight on the circadian amplitude and robustness [197], it also suggests that physical activity may influence the relationship between light exposure and diabetes risk. However, another mechanism for the association between circadian misalignment and metabolic disorders cannot be ruled out. Zambrano et al. [198] showed that a simultaneous increase in insulin and melatonin levels leads to a deterioration in insulin signal transduction in adipocytes in vitro. It cannot be excluded that a similar effect will be caused by regular consumption of high-glycemic-index food late in the evening/at night, as well as regular intake of pharmacological preparations of melatonin before dinner. Overall, aligned circadian rhythms of physical activity and daylight exposure, with sufficient activity and light exposure during daytime hours, facilitate a strong circadian amplitude and robustness, also of the circadian rhythm in temperature [197,199,200,201,202]. Small amplitudes and shifted phases of circadian rhythms in physical activity are attributes of depressed individuals [80,81,82] and of individuals with binge eating disorder [83]. Fragmentation of the physical activity rhythm was linked to food addiction and emotional eating in young adults [203].

6. Molecular Insights on the Interaction Between Timed Physical Activity and Brain Health

Regular physical activity and optimally scheduled exercise exert multifaceted effects on health and well-being, helping to improve metabolic health via modulating the lipid profile [204,205,206,207] and reducing inflammation [208]. Optimization of exercise by its timing can be particularly useful for maintaining healthy triglycerides, TG [209], and the ratio between TG and high-density lipids, HDL, since these lipids are closely coupled with circadian factors [53,210,211]. Effects of optimally scheduled physical activity involve the modulation of metabolomics [212], which establishes the molecular background for brain health [208,213]. Even short-term (about 30 min) bouts of physical activity improved inflammatory profiles by increasing adiponectin while decreasing leptin and interleukin-6 [214], while also increasing brain-derived neurotrophic factor (BDNF) and insulin-like growth factor 1 (IGF-1) [215]. Regular physical activity can influence protein synthesis and breakdown, which can affect the 24 h balance of lipids and amino acids. For instance, scheduled physical activity can provide cardio-metabolic protection by stimulating the production of lactoylphenylalanine, or Lac-Phe, by carnosine dipeptidase II (CNDP2) cells in diverse tissues that reduces food intake without affecting motor activity or energy expenditure [216]. It has potential effects on food addiction, mood, depression, and anxiety, and it also regulates the timing of food intake, which can be a necessary co-factor for exercise to maintain metabolic health [217,218].
Acute moderate physical exercise improves lipid metabolism via increasing circulating 12,13-dihydroxy-9Z-octadecenoic acid (12,13-diHOME) in men and women of different age groups [219]. Activity modulates regulatory factors of the circadian rhythm (Dbp, Tef, Nr1d2, and Per3) in mesenchymal stem cells, the process that was shown to be crucial for multi-tissue molecular responses to exercise and obesity [220]. Physical activity is coupled with the central carbon metabolism, which involves glycolysis and the pentose-phosphate pathway (PPP) that works to oxidize glucose, resulting in the production of NADH and NADPH. NADPH metabolism modulates circadian rhythm parameters, including the period length of the circadian activity rhythm via the pentose-phosphate pathway [221].
Such interaction between the circadian clock and the timing of physical activity recruits the nuclear factor Nrf2 (erythroid-derived 2)-like 2) pathway. Nrf2 is a transcription factor involved in the expression of over 250 genes, i.e., providing feedback between redox oscillations and the circadian transcriptional rhythms through the secondary core-clock loop gene NR1D [221,222]. Nrf2 also affects brain functions, increasing glucose uptake in neurons and astrocytes [223]. Nrf2 is also involved in maintaining large-amplitude circadian rhythms in organs and tissues by regulating expression of the core-clock Cry2 gene [224]. Therefore, major beneficial effects of timed exercise may rely on the interaction between Nrf2 and glucose metabolism [225].
Greater benefits of evening exercise in patients with metabolic disorders are hypothesized to be explained by the Nrf2-dependent activation of the antioxidant response element (ARE) region in skeletal muscles, binding to the promoter region of the interleukin 6 (IL-6) gene. Transcription and translation of IL-6 protein are thereby increased, which then stimulates AMP-activated protein kinase (AMPK), which itself is activated by exercise and also activates Nrf2, closing this feedback loop [225]. Physical activity activates PPARs (peroxisome proliferator-activated receptors) [226] that help to integrate the circadian clocks with energy metabolism [227] and are expressed in mammalian tissues in a circadian-dependent manner [228]. Given that the balance between these factors differs between morning and evening, the effects of exercise at different times of day also vary [225].
In a mouse model, lifelong exercise exerted geroprotective effects by restoring (mainly by readjusting) the rhythmic machinery via the core circadian clock protein BMAL1 and resetting circadian transcriptomic programs of younger animals, mainly in the central nervous system and vascular endothelial cells [229]. Sustained physical activity exerts profound effects on the endogenous endocannabinoid system that may help to enhance mood and learning abilities and modulate the endogenous 24 h balance of serotonin, melatonin, and dopamine [230], especially in the presence of sufficient outdoor exposure to sunlight [197].

7. Wearables to Track Circadian Markers in Neurodegenerative Diseases

Alterations in the interaction between light exposure and circadian rhythms can be utilized to track early changes associated with neurobehavioral and neurodegenerative pathologies. Precision measurement is essential to increase statistical power and ensure reproducibility in human neuroscience, potentially revolutionizing the field through enhanced methodological rigor and improved scientific outcomes [231]. Research suggests a significant correlation between metabolic changes and the progression of neurodegenerative diseases. Epidemiological studies have consistently linked conditions like obesity and metabolic disorders to the onset of neurodegenerative diseases [232,233]. Hormones such as leptin, ghrelin, insulin, and IGF-1 play a central role in protecting against neuronal damage, resisting harmful stimuli, and other neurodegenerative mechanisms [233].
In addition to actigraphy, wearable GPS sensors and commercial accelerometers offer a non-invasive method for monitoring the mobility and physical activity of individuals with neurodegenerative disorders, potentially serving as biomarkers for disease tracking and treatment response. Despite challenges in standardizing remote monitoring methods [26], recent research [234] has shown limited use of GPS but extensive application of accelerometers in patients with neurodegenerative disorders, resulting in promising clinical trial outcomes and strong correlations with disease progression and patient activities. The next steps involve standardizing these technologies for broader application and validation of their effectiveness in larger patient populations to improve disease monitoring and management. A meta-analysis of 48 studies on circadian disruption in dementia using wearable technology revealed that adults with dementia exhibit lower activity levels, disrupted sleep–wake patterns, increased fragmentation, and reduced normal daytime activity compared to non-dementia individuals [235].
The main circadian brain clock synchronizers, such as light [236,237] and melatonin [92,154,155,238,239,240], can be effective in preventing and/or mitigating neuroinflammation and neurodegeneration. Enhancement of circadian light signaling by daytime light exposure and/or melatonin administration at night can improve circadian robustness by increasing the circadian amplitude, aligning the phase, and strengthening signal robustness in overt phenotypic functions measured by wearables. However, currently, very few studies have addressed light or melatonin therapies using protocols that are personalized for an individual patient’s circadian phase or chronotype. However, a recent phase 2 clinical trial showed that biologically directed daylight therapy improved restorative deep sleep in individuals with mild to moderate Parkinson’s disease, with no significant difference between controlled daylight and melanopsin booster light [37]. The findings suggest that personalized indoor daylight therapy could be effective in improving sleep in early to moderate stages of the disease, calling for further research in advanced Parkinson’s disease.
We recently reviewed newer actigraphs that are available to assess circadian light hygiene for appearance, dimensions, weight, mounting, battery, sensors, features, communication interface, and software [40]. Actigraphs equipped with light sensors can help to track the intensity and duration of light exposure throughout the day, analyze its effect on circadian rhythms, and adjust an individual’s light exposure (circadian light hygiene) according to the recent recommendations [181]. These data help quantify the amount of light a person is exposed to during different times of the day, including natural light from the sun and artificial light sources indoors. The timing of light exposure can be analyzed relative to key circadian markers, such as the onset of melatonin secretion in the evening and the offset of melatonin secretion in the morning. This information helps assess whether individuals’ light exposure aligns with their natural circadian rhythms. By correlating light exposure data from actigraphy with sleep patterns, researchers can evaluate how light exposure influences the timing and quality of sleep.
In a recent study of Arctic residents [53] during the spring equinox, a higher BMI was found to be linked to higher blue light exposure within distinct time windows and also to a lower wrist temperature MESOR. An evening time window between 9:30 p.m. and 0:30 a.m. was identified when 95% confidence intervals of blue light exposure (BLE) were non-overlapping between groups with a BMI < 25 or BMI > 25 kg/m2. Such link was coupled to the MTNR1B rs10830963 G-allele. A novel Nocturnal Excess Index (NEI) was suggested to estimate evening light overexposure along with the Daylight Deficit Index (DDI), which was associated with morning cortisol values [53]. Another study used a method known as FOSR to divide an average 24 h activity signal into 48 30 min segments and evaluate differences between two groups within each 30 min segment. This approach found that the Aβ-positive group exhibited significantly higher activity levels than the Aβ-negative group between 1:00 p.m. and 3:30 p.m. Additionally, by analyzing the standard deviation of activity in each segment, the authors demonstrated that the Aβ-positive group displayed more consistent activity patterns during the early afternoon throughout the recording period [54]. In this study, light exposure was not assessed, although it is likely that episodes of elevated activity and corresponding variability could be attributed to simultaneous differences in light exposure. Indeed, some studies suggest that excessive evening light may be linked to cognitive impairment [241,242]. A characteristic motor activity profile in older adults with dementia has been previously described, termed “sundowning”—an increase in the level of motor activity in the late afternoon [234,243,244], occurring in approximately 20% of patients with Alzheimer’s disease [245].
In neurodegenerative diseases, the function of retinal ganglion cells (RGCs), notably the intrinsically photosensitive cells (ipRGCs), is compromised [246,247,248]. Compromised light signaling due to progressive loss of ganglion cells, including ipRGCs, is most evident in advanced stages of glaucoma, being associated with complex circadian disruptions, including changes in circadian alignment and robustness [69,92,103,154,155,211], altered mood [70], and sleep [69,154,155,249]. Similarly, in Alzheimer’s disease, impaired visual function is associated with sleep/wake disorders and cognitive decline [250]. Such alterations can be linked to a decreased amplitude of light–dark alternation, since both melatonin [92,154,155] and daylight [251] mitigate circadian disruptions. Similarly, enhancing spectral lens transmission after cataract replacement improves circadian health [252].
Besides neuroinflammation and neurodegeneration, some other factors, such as a history of SARS-CoV-2 infection, may change the susceptibility to circadian light hygiene, likely affecting light perception or sensitivity. A recent study showed that populations with a history of COVID-19 had lower daytime exposure to white, blue, and ultraviolet B light [253]. Those who had poor circadian light hygiene (estimated by a smaller normalized circadian amplitude) were more susceptible to circadian disruptions, manifested as a phase delay, small amplitude, and less robust circadian patterns of activity and delayed sleep. Furthermore, the longer the time elapsed since their COVID-19 diagnosis, the poorer circadian light hygiene the patients had.

8. Boosting Brain, Vascular and Metabolic Health by Clock-Enhancing Strategies

8.1. Scheduled Physical Activity

To explore the mechanisms that underpin the relationship between scheduled circadian physical activity and the maintenance of proper light hygiene, we examine their role in promoting strong and stable circadian rhythms. Physical activity is closely linked to circadian health since it occurs regularly within the active phase of the 24 h rhythm, which is usually daytime for humans. The circadian clock can be entrained primarily by light but also by physical activity and meals [197,204,254]. This means that the timing of these daily routines can influence the body’s internal clock, helping to regulate the sleep–wake cycle and other physiological processes. This complex interaction highlights the importance of maintaining consistent routines and healthy habits for overall well-being. Most common health risks related to circadian disruption, such as a reduced amplitude, a delayed phase, increased instability, and fragmentation of rhythms, can be mitigated by physical activity. Animal studies showed the stabilizing effect of physical activity on the circadian rhythm [255,256]. The effect of stable circadian activity rhythms for learning and memory was also shown [257,258].
Exercise timing occurring at the post-absorptive phase was shown to cause greater fat oxidation compared to postprandial exercise, as confirmed by indirect calorimetry and 13C magnetic resonance spectroscopy [259]. Timed physical activity, such as morning exercise, decreased abdominal fat and blood pressure in women, while evening exercise improved muscular performance. In men, evening workouts boosted fat oxidation and lowered systolic blood pressure regardless of macronutrient intake [260]. Timed physical activity is promising to handle neurodegenerative pathologies [261].
Furthermore, personalized physical activity adjusted for individual differences [262,263], including individual circadian clock features such as phase and amplitude, may both preserve robust circadian rhythms and enhance benefits of physical activity for systemic and mental health [197]. A study showed that similar to light or melatonin, phase response curves to exercise and physical activity exist [264], assuming that scheduled timing of regular physical activity may facilitate circadian phase correction. A high order of “fitness” or robustness of circadian rhythms is generally linked to a younger age and a better health status [11,12]. Recent UK Biobank-based studies found that engaging in moderate physical activity can help reduce the negative influence of both short and long sleep duration on the risk of all-cause mortality and cardiovascular disease [265] and the effect of short sleep on the incidence of type 2 diabetes [266].
The analysis of UK Biobank actigraphy data from 2324 atrial fibrillation patients revealed that engaging in over 105 min of moderate-to-vigorous physical activity weekly reduces the risks of heart failure and all-cause mortality [267]. Intense sporadic “lifestyle physical activity” was correlated with a reduced incidence of cancer risk, according to a prospective cohort study analyzing 22,398 self-reported sedentary adults from the UK Biobank accelerometry subsample [268]. Increased activity, even when concentrated within 1 to 2 days each week (“weekend-warrior” patterns), may be effective for improving cardiovascular risk profiles [269].
Similarly, both regular and weekend warrior patterns of moderate physical activity, above the 150 min per week recommended by the WHO, are associated with an equal reduction in Parkinson’s disease risk [270]. Another study suggested a linear relationship between physical activity and cardiovascular health, revealing that individuals with higher levels of physical activity consistently exhibit a reduced risk of cardiovascular disease, with the most substantial benefits observed in those who maintain the highest intensity of activity [271]. A longitudinal analysis of 86,556 UK Biobank participants over an average follow-up of 6 years demonstrated that greater overall physical activity and increased daily step count were significantly linked to a reduced incidence of cancers [272]. In a study of 81,717 UK Biobank participants, it was observed that increased engagement in physical activity correlated with reduced hospitalization risks for nine out of the twenty-five most frequent hospitalization causes, with the most significant risk reductions seen in gallbladder disease, diabetes, and urinary tract infections [273]. In a US cohort study involving 7607 adults, an increased accumulation of light-intensity and moderate-to-vigorous-intensity physical activities was found to be inversely associated with stroke risk, whereas extended periods of sedentary behavior correlated with an elevated risk [274].
Our body’s circadian rhythms govern various physiological processes, including the timing and intensity of physical activity. Disruptions to these rhythms, such as irregular sleep patterns or inconsistent exercise schedules, can have a detrimental effect on mental well-being. Vice versa, regular physical activity can contribute to improving mood, reducing stress, and enhancing cognitive functions [275,276,277,278]. Not only aspects of regularity and intensity of exercise were effective to improve health and reduce risks of cardiovascular and metabolic pathologies, but timing of exercise is also important [279,280,281]. Recently accumulated evidence underlines the benefits of exercise scheduled according to the circadian clock and chronotype, also aiding metabolic health [262]. Therefore, optimization of regular circadian timing of physical exercise can be an effective way to manage symptoms of anxiety, depression, and other mental health conditions.
Aligning physical activity with our body’s internal clock can help optimize performance, recovery, and overall psychological well-being. Incorporating exercise into our daily routine at consistent times can help regulate our circadian rhythms, leading to improved sleep quality, increased energy levels, and improved mental clarity. By synchronizing physical activity with our body’s natural rhythms, we can promote psychological resilience, enhance brain function, and better cope with the demands of daily life. To date, personalized recommendations for timing exercise, while important, are usually overlooked. In the case of blood pressure, an N-of-1 study showed that exercise in the evening—but not in the morning—increased the 24 h amplitude. Since the participant had an excessive 24 h amplitude of blood pressure, the personalized recommendation was to exercise in the morning, while for others, evening exercise could be beneficial in strengthening a weakened circadian rhythm [281].

8.2. Light Hygiene and Chronobiotics

Circadian health improvement strategies can balance the timing and amount of melatonin and daylight. Boosting circadian signals through exposure to daylight [37,282,283,284,285,286] or administering melatonin during the nighttime [92,287,288] can strengthen the circadian system. Personalization of dose and timing of melatonin administration can be most important for its effective supplementation. Evening low-dose melatonin lowered high blood pressure in hypertensive patients [288] and intraocular pressure in patients with glaucoma [92], with the greatest lowering effect achieved in the morning. Melatonin also reduced glycosylated hemoglobin levels (HbA1c) and increased high-density lipoprotein-cholesterol [97,289]. Melatonin can be more effective in combination with an enhanced dynamic range of light exposure.
Improving the lighting conditions in the surroundings with adaptable lighting systems positively influenced the mood and behavior of elderly individuals [287,290]. In agreement with phase-response curves [291,292,293], morning/daytime light and evening/nocturnal melatonin facilitate circadian phase advancements, preventing complex negative aspects of late chronotypes [294,295,296,297]. The combination of light therapy with melatonin [298,299] or physical activity [300] can be effective in neurodegenerative diseases, including glaucoma [92,154,155]. Light regularity may help to maintain sleep regularity, even in healthy young adults [301].
Timed physical activity may have greater circadian effects when it coincides with daylight exposure [197], better circadian light hygiene per se may have metabolic benefits [122]. At high latitudes, a larger amplitude and an earlier phase of light exposure, mirrored by a greater amplitude and an earlier phase of melatonin and by an earlier sleep phase, characterize seasons with a more comfortable circadian light hygiene. These features are also associated with better proxies of metabolic health, even when there are no differences in the patterns of physical activity [123]. Proper timing of intake of some other substances with pronounced circadian effects, such as coffee, can also provide benefits for metabolism and overall health: morning coffee consumption is strongly associated with lower all-cause, cardiovascular, and cancer-specific mortality [302]. It can also enhance the effects of timed exercise by boosting peak power, readiness for physical efforts, and cognitive performance [303].
Overall, circadian health rescue or enhancement implies maintenance of due amplitude, phase alignment, and stability of the signals that govern overt bodily functions (activity, temperature, heart rate, blood pressure, etc.), trackable by wearable devices.

8.3. Optimizing Weekly Schedules

The optimal time to exercise needs to be personalized not only in terms of daytime but also on the weekly scale. Currently, there is a lack of agreement regarding the optimal duration, intensity, timing, and frequency of weekly physical activity for health maintenance. For instance, inconsistencies exist between research findings. One study [269] suggests that one to two weekly sessions of physical activity—termed “weekend warrior” sessions—are adequate for reducing cardiovascular risk comparably to physical activity that is more evenly distributed throughout the week. Other studies, however, conclude that such infrequent activity does not achieve an equivalent reduction in the cardio-metabolic index [304] or lipid accumulation products [305]. A potential explanation for the differing results might be the age of the target population, databases consulted, endpoints used, or the need for individualization. The UK study by Khurshid et al. [269] encompassed individuals aged 40–69 years from the UK Biobank, whereas the research by Xue et al. [304] focused on a distinct cohort from the US National Health and Nutrition Examination Survey (NHANES). The latter study determined that the correlation between physical activity and the cardio-metabolic index was more significant in subgroups aged below 45 or above 60.
An additional crucial detail when studying weekly patterns pertains to the infradian rhythms of physical activity. Employing chronobiological and mathematical modeling to analyze meticulously the distribution of intensity patterns across the 24 h span and throughout the week could provide greater insight into this matter.

9. Perspectives of Actigraphy-Compatible Wearable Technologies/Next-Generation Comprehensive Monitoring Systems

The simultaneous tracking of different physiological variables provides a more complete picture of an individual’s circadian health status. The ability to detect subtle changes in physiological and neurological patterns could lead to earlier and more accurate diagnoses of conditions like sleep disorders, depression, and neurodegenerative or metabolic diseases. For research and diagnostic purposes, this integrated approach would require effective methods for combining data from different sources while maintaining data integrity, advanced computational methods to analyze the complex data, ways to extract meaningful patterns, and a strategy to rigorously test the results thus obtained and validate the clinical relevance of the findings.
Focus on extra-circadian frequency domains: ultradian rhythms, or biological rhythms with a period shorter than 24 h, can reflect various physiological and neurological functions. Ultradian fluctuations in brain functions [47,306,307] are under-investigated, though a promising area of research that can utilize ultradian fluctuations and their beat harmonics to untangle complex interactions for a better understanding of biological processes and diagnostics applications. Beat harmonics refer to the composite frequencies produced when two or more ultradian rhythms interact, much like the overlapping waves in acoustics that create a new rhythm or “beat”, providing deeper insights into the synchronization of biological rhythms. Furthermore, in-sync vs. out-of-sync ultradian harmonics may have different outputs, such as non-overlapping lower-frequency oscillations that can be meaningful. The concept of using data from wearables to investigate extra-circadian modulations is innovative and holds potential for advancing medical diagnostics. The analysis of ECG data in specific frequency domains also offers insight into the functioning of specific brain areas [308,309,310,311,312].

9.1. Functional Near-Infrared Spectroscopy (fNIRS) and Photoplethysmography (PPG)

For example, integrating variables obtained by photoplethysmography [313,314,315,316,317,318] or functional near-infrared spectroscopy (fNIRS) [319,320] with next-generation wearables may offer a comprehensive approach to monitoring and analyzing physiological and neurological functions. fNIRS stands out as a hemodynamics method that offers significant advantages [321], particularly in terms of its portability and greater motion tolerance, areas where functional magnetic resonance imaging (fMRI) faces constraints [322]. Wearable fNIRS could be applied to better understand time-specified windows of global vs. local brain signal fluctuations and functional connectivity, as suggested by previous fMRI studies [323,324].

9.2. Biochemical Analyses

Biochemical analyses are being developed and can be integrated into wearables in the proximal future [20,325,326,327,328,329,330,331]. Sweat-based wearable-enabling technology was recently proposed to track cortisol [332] and inflammation markers such as interleukin-1β and C-reactive protein [326,327]. To advance the understanding of perspiration’s role in thermoregulation and its applied use for physiological monitoring, innovative microfluidic patches with hierarchical superhydrophilic biosponges and integrated sensors should be adopted for efficient, real-time sweat analysis during various activities and conditions [333]. Cutting-edge wearable technologies will have the capability to track the golden standard circadian phase marker, melatonin, but also leptin and ghrelin [20].

9.3. Improving Light Exposure Monitoring and Analytics

Melanopic equivalent daylight illuminance (mEDI) is a metric used to quantify the effect of light on the melanopsin-containing intrinsically photosensitive retinal ganglion cells (ipRGCs) in the human eye [181,334,335,336,337]. These cells have a peak sensitivity in the shorter wavelength part of the visible spectrum and play an important role in regulating circadian rhythms. Melanopic EDI measures the effectiveness of light in stimulating these cells, relative to a standard daylight (D65) condition. It is a valuable measure for understanding how different light sources affect our biological clock and other non-image-forming (NIF) effects of light. To accurately determine the melanopic EDI, it is essential to measure irradiance and the spectral distribution of a light source. This is of importance because the color temperature of daylight fluctuates depending on the time of day, and light sources found in various home environments and offices may have different spectral compositions. Further advancements in actigraphy capable of measuring the spectral distribution or directly the melanopic EDI are necessary for this purpose. Furthermore, positioning wearable light loggers or dosimeters closer to the eyes, such as with the lido [338], can refine the assessment of light exposure.
Understanding the user’s challenges of wearing light dosimeters is key to designing devices that are more acceptable and supporting research into light exposure and its effects on health and behavior. To improve the wearer’s experience and compliance, and therefore data quality, the device should be designed to be unobtrusive. Devices should be adapted to the needs of different patient populations and mounting/body location methods. In addition, comprehensive user training and motivational incentives can improve the compliance of the wearer. The implementation of these recommendations will improve the quality of data collected by wearable light loggers. While most actigraph models cannot measure melanopic EDI directly, some are equipped with RGB light sensors [40]. For an overview of current wearable light loggers and their specifications, see [335]. Devices like the ActTrust, for example, can also monitor light intensity in the ultraviolet A (UVA), ultraviolet B (UVB), and infrared (IR) wavelength ranges.
While this feature has not been extensively explored yet, the ability to gather precise data on UV and IR light exposure in real time holds significant potential for various health and therapeutic uses [339,340,341]. For instance, it could be instrumental in managing conditions such as autoimmune diseases, mood and metabolic disorders, as well as addictions [342,343]. Scientifically valid information on UV exposure can also be collected by commercially available wearables [344]. Clinical records underscore the role of circadian rhythms in determining health results and guiding medical procedures, especially when using data from electronic health records. Yet, due to the lack of uniformity in collection methods and equipment, harnessing electronic health records for chronomedicine demands addressing built-in biases and data patterns unrelated to biology [345]. The precision of light logging can be further enhanced by improving light sensors and rendering their position closer to the eyes [338]. Improving their metrology [346] should improve the assessment of physiological effects of natural light and human-centric light technologies [347].
Many commercial light loggers lack transparency in critical technical aspects such as sensor types and data processing methods. This opacity can lead to inaccuracies, undetected errors, or incomplete data sets, making it difficult to ensure the accuracy and comparability of results between different devices. As a result, there is an urgent need for a standardized methodology to collect and analyze data from wearable light loggers. The project “Metrology for Wearable Light Loggers and Optical Radiation Dosimeters” (22NRM05, MeLiDos) will develop the measurement and data analysis methods needed to characterize and validate wearable light loggers. In addition, the JTC 20 (D6/D2) technical report on wearable alpha-optic dosimetry and light logging will provide a comprehensive review of current practices in the scientific literature. Additional sensors incorporating heart rate [348], oxygen saturation [349,350], and functional near-infrared spectroscopy techniques fNIRS [351,352] may enhance the informative capacity of wearable technologies for digital phenotyping in the near future. Despite their limited precision, commercially available smartphone-compatible wearables are already used to evaluate sleep disorders, cardio-metabolic, mental health, and well-being, but the lack of standardization is causing marked disagreement between devices [86,353,354,355,356,357].

9.4. Perspectives

Currently, there is consensus on optimal duration of data sampling, inclusion of both free days and working days, minimal sampling requirements, and allowed gaps within samplings. However, there are no clear definitions of normal ranges and how such ranges vary depending on methods of data analysis and critical environmental factors such as local environmental light conditions. Reference standards should aid in the development of diagnostic criteria and treatment guidelines, notably for sleep-related conditions. They would serve as benchmarks for assessing treatment efficacy and monitoring patient progress over time. Overall, the development of reference standards for actigraphy-based indices would enhance the utility of actigraphy in clinical practice and research, ultimately improving our understanding of sleep and circadian rhythms and advancing personalized approaches to healthcare. While deviations from normative values in actigraphy-related variables may often lack specificity, they can nonetheless serve as a catalyst for initiating a comprehensive series of tests. This approach aims to identify the underlying causes, facilitating an earlier diagnosis in the disease progression, when treatment is more likely to be effective.
New sensor technologies, enabling the collection of big data sets, to be organized in large repositories, integrated with artificial intelligence (AI), are expected to further enhance the prediction of health hazards and upgrade the interpretation of circadian health by wearables. Monitoring a broader range of health proxies with standardized sampling requirements, empowered by sophisticated AI algorithms, will allow personalized chronodiagnosis and may encourage large-scale studies to explore the interplay between genetic background, environmental factors, lifestyle factors, and circadian health outcomes. This holistic approach should facilitate the development of targeted interventions to optimize health and well-being in diverse populations, based on their distinct genetic predispositions and specifics of environmental factors and lifestyle. As these technologies evolve, they are expected to offer truly personalized prevention and management capabilities of circadian-related disorders.

Author Contributions

Conceptualization, D.G. and G.C.; methodology, D.G., O.S., M.B., K.O. and G.C.; software, D.G. and G.C.; validation, D.G., D.W., M.B. and G.C.; resources, D.G.; writing—original draft preparation, O.S., D.W., M.B., K.O. and G.C.; writing—review and editing, all authors.; visualization, D.G., D.W. and G.C.; supervision, D.G.; project administration, D.G.; funding acquisition, D.G. and M.B. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the West-Siberian Science and Education Center, Government of Tyumen District, Decree of 20.11.2020, No. 928-rp. The funding organizations had no role in the design or conduct of this research. The author(s) have no proprietary or commercial interest in any materials discussed in this article.

Conflicts of Interest

The authors declare no conflicts of interest. The funder had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. López-Otín, C.; Kroemer, G. Hallmarks of health. Cell 2021, 184, 1929–1939. [Google Scholar] [CrossRef] [PubMed]
  2. Agadzhanian, N.A.; Gubin, D.G. Desinkhronoz: Mekhanizmy razvitiia ot molekuliarno-geneticheskogo do organizmennogo urovnia [Desynchronization: Mechanisms of development from molecular to systemic levels]. Usp. Fiziol. Nauk. 2004, 35, 57–72. (In Russian) [Google Scholar] [PubMed]
  3. Cornelissen, G.; Otsuka, K. Chronobiology of Aging: A Mini-Review. Gerontology 2017, 63, 118–128. [Google Scholar] [CrossRef] [PubMed]
  4. Cederroth, C.R.; Albrecht, U.; Bass, J.; Brown, S.A.; Dyhrfjeld-Johnsen, J.; Gachon, F.; Green, C.B.; Hastings, M.H.; Helfrich-Förster, C.; Hogenesch, J.B.; et al. Medicine in the Fourth Dimension. Cell Metab. 2019, 30, 238–250. [Google Scholar] [CrossRef]
  5. Fishbein, A.B.; Knutson, K.L.; Zee, P.C. Circadian disruption and human health. J. Clin. Investig. 2021, 131, e148286. [Google Scholar] [CrossRef] [PubMed]
  6. Roenneberg, T.; Foster, R.G.; Klerman, E.B. The circadian system, sleep, and the health/disease balance: A conceptual review. J. Sleep Res. 2022, 31, e13621. [Google Scholar] [CrossRef]
  7. Gubin, D. Chronotherapeutic Approaches. In Chronobiology and Chronomedicine: From Molecular and Cellular Mechanisms to Whole Body Interdigitating Networks; Cornelissen, G., Hirota, T., Eds.; Royal Society of Chemistry: London, UK, 2024; Volume 23, Chapter 21; pp. 536–577. [Google Scholar]
  8. Allada, R.; Bass, J. Circadian Mechanisms in Medicine. N. Engl. J. Med. 2021, 384, 550–561. [Google Scholar] [CrossRef]
  9. Kramer, A.; Lange, T.; Spies, C.; Finger, A.-M.; Berg, D.; Oster, H. Foundations of circadian medicine. PLoS Biol. 2022, 20, e3001567. [Google Scholar] [CrossRef]
  10. Gubin, D.G. Molecular basis of circadian rhythms and principles of circadian disruption. Usp. Fiziol. Nauk. 2013, 44, 65–87. (In Russian) [Google Scholar] [PubMed]
  11. Gubin, D.; Cornelissen, G.; Weinert, D.; Vetoshkin, A.S.; Gapon, L.I.; Shurkevich, N.P.; Poshinov, F.A.; Belozerova, N.V.; Danilova, L.A. Circadian disruption and Vascular Variability Disorders (VVD)—Mechanisms linking aging, disease state and Arctic shift-work: Applications for chronotherapy. World Heart J. 2013, 5, 285–306. [Google Scholar]
  12. Gubin, D.G.; Weinert, D.; Bolotnova, T.V. Age-Dependent Changes of the temporal Order—Causes and Treatment. Curr. Aging Sci. 2015, 9, 14–25. [Google Scholar] [CrossRef] [PubMed]
  13. Cornelissen, G. Cosinor-based rhythmometry. Theor. Biol. Med. Model. 2014, 11, 16. [Google Scholar] [CrossRef]
  14. Weinert, D.; Gubin, D. Chronobiological Study Designs. In Chronobiology and Chronomedicine from Molecular and Cellular Mechanisms to Whole Body Interdigitating Networks; Cornelissen, G., Hirota, T., Eds.; Royal Society of Chemistry: London, UK, 2024; Volume 23, Chapter 22; pp. 579–609. [Google Scholar]
  15. Usmani, I.M.; Dijk, D.-J.; Skeldon, A.C. Mathematical Analysis of Light-sensitivity Related Challenges in Assessment of the Intrinsic Period of the Human Circadian Pacemaker. J. Biol. Rhythm. 2024, 39, 166–182. [Google Scholar] [CrossRef] [PubMed]
  16. Kräuchi, K.; Cajochen, C.; Werth, E.; Wirz-Justice, A. Functional link between distal vasodilation and sleep-onset latency? Am. J. Physiol. Integr. Comp. Physiol. 2000, 278, R741–R748. [Google Scholar] [CrossRef]
  17. Kräuchi, K. The thermophysiological cascade leading to sleep initiation in relation to phase of entrainment. Sleep Med. Rev. 2007, 11, 439–451. [Google Scholar] [CrossRef] [PubMed]
  18. Depner, C.M.; Cheng, P.C.; Devine, J.K.; Khosla, S.; de Zambotti, M.; Robillard, R.; Vakulin, A.; Drummond, S.P.A. Wearable technologies for developing sleep and circadian biomarkers: A summary of workshop discussions. Sleep 2020, 43, zsz254. [Google Scholar] [CrossRef] [PubMed]
  19. Li, X.; Kane, M.; Zhang, Y.; Sun, W.; Song, Y.; Dong, S.; Lin, Q.; Zhu, Q.; Jiang, F.; Zhao, H. Circadian Rhythm Analysis Using Wearable Device Data: Novel Penalized Machine Learning Approach. J. Med. Internet Res. 2021, 23, e18403. [Google Scholar] [CrossRef] [PubMed]
  20. Lujan, M.R.; Perez-Pozuelo, I.; Grandner, M.A. Past, Present, and Future of Multisensory Wearable Technology to Monitor Sleep and Circadian Rhythms. Front. Digit. Health 2021, 3, 721919. [Google Scholar] [CrossRef]
  21. Shandhi, M.H.; Wang, W.K.; Dunn, J. Taking the time for our bodies: How wearables can be used to assess circadian physiology. Cell Rep. Methods 2021, 1, 100067. [Google Scholar] [CrossRef]
  22. Tobin, S.Y.; Williams, P.G.; Baron, K.G.; Halliday, T.M.; Depner, C.M. Challenges and Opportunities for Applying Wearable Technology to Sleep. Sleep Med. Clin. 2021, 16, 607–618. [Google Scholar] [CrossRef]
  23. Lin, C.; Chen, I.-M.; Chuang, H.-H.; Wang, Z.-W.; Lin, H.-H.; Lin, Y.-H. Examining Human-Smartphone Interaction as a Proxy for Circadian Rhythm in Patients with Insomnia: Cross-Sectional Study. J. Med. Internet Res. 2023, 25, e48044. [Google Scholar] [CrossRef]
  24. de Zambotti, M.; Goldstein, C.; Cook, J.; Menghini, L.; Altini, M.; Cheng, P.; Robillard, R. State of the science and recommendations for using wearable technology in sleep and circadian research. Sleep 2023, 47, zsad325. [Google Scholar] [CrossRef]
  25. Moorthy, P.; Weinert, L.; Schüttler, C.; Svensson, L.; Sedlmayr, B.; Müller, J.; Nagel, T. Attributes, Methods, and Frameworks Used to Evaluate Wearables and Their Companion mHealth Apps: Scoping Review. JMIR mHealth uHealth 2024, 12, e52179. [Google Scholar] [CrossRef] [PubMed]
  26. della Monica, C.; Ravindran, K.K.G.; Atzori, G.; Lambert, D.J.; Rodriguez, T.; Mahvash-Mohammadi, S.; Bartsch, U.; Skeldon, A.C.; Wells, K.; Hampshire, A.; et al. A Protocol for Evaluating Digital Technology for Monitoring Sleep and Circadian Rhythms in Older People and People Living with Dementia in the Community. Clocks Sleep 2024, 6, 129–155. [Google Scholar] [CrossRef] [PubMed]
  27. Sun, H.; Ganglberger, W.; Panneerselvam, E.; Leone, M.J.; Quadri, S.A.; Goparaju, B.; Tesh, R.A.; Akeju, O.; Thomas, R.J.; Westover, M.B. Sleep staging from electrocardiography and respiration with deep learning. Sleep 2020, 43, zsz306. [Google Scholar] [CrossRef] [PubMed]
  28. Kranzinger, S.; Baron, S.; Kranzinger, C.; Heib, D.; Borgelt, C. Generalisability of sleep stage classification based on interbeat intervals: Validating three machine learning approaches on self-recorded test data. Behaviormetrika 2023, 51, 341–358. [Google Scholar] [CrossRef]
  29. Kripke, D.F.; Mullaney, D.; Messin, S.; Wyborney, V.G. Wrist actigraphic measures of sleep and rhythms. Electroencephalogr. Clin. Neurophysiol. 1978, 44, 674–676. [Google Scholar] [CrossRef] [PubMed]
  30. Wilde-Frenz, J.; Schulz, H. Rate and Distribution of Body Movements during Sleep in Humans. Percept. Mot. Ski. 1983, 56, 275–283. [Google Scholar] [CrossRef]
  31. Borbély, A.A. New techniques for the analysis of the human sleep-wake cycle. Brain Dev. 1986, 8, 482–488. [Google Scholar] [CrossRef] [PubMed]
  32. Ancoli-Israel, S.; Cole, R.; Alessi, C.; Chambers, M.; Moorcroft, W.; Pollak, C.P. The Role of Actigraphy in the Study of Sleep and Circadian Rhythms. Sleep 2003, 26, 342–392. [Google Scholar] [CrossRef]
  33. Patterson, M.R.; Nunes, A.A.S.; Gerstel, D.; Pilkar, R.; Guthrie, T.; Neishabouri, A.; Guo, C.C. 40 years of actigraphy in sleep medicine and current state of the art algorithms. npj Digit. Med. 2023, 6, 51. [Google Scholar] [CrossRef] [PubMed]
  34. Lévi, F.; Zidani, R.; Misset, J.-L. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet 1997, 350, 681–686. [Google Scholar] [CrossRef]
  35. Kramer, G.; Dominguez-Vega, Z.T.; Laarhoven, H.S.; Brandsma, R.; Smit, M.; van der Stouwe, A.M.; Elting, J.W.J.; Maurits, N.M.; Rosmalen, J.G.; Tijssen, M.A. Similar association between objective and subjective symptoms in functional and organic tremor. Park. Relat. Disord. 2019, 64, 2–7. [Google Scholar] [CrossRef] [PubMed]
  36. Leng, Y.; Blackwell, T.; Cawthon, P.M.; Ancoli-Israel, S.; Stone, K.L.; Yaffe, K. Association of Circadian Abnormalities in Older Adults with an Increased Risk of Developing Parkinson Disease. JAMA Neurol. 2020, 77, 1270–1278. [Google Scholar] [CrossRef]
  37. Feigl, B.; Lewis, S.J.; Burr, L.D.; Schweitzer, D.; Gnyawali, S.; Vagenas, D.; Carter, D.D.; Zele, A.J. Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson’s disease: A randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial. eClinicalMedicine 2024, 69, 102474. [Google Scholar] [CrossRef]
  38. Winer, J.R.; Lok, R.; Weed, L.; He, Z.; Poston, K.L.; Mormino, E.C.; Zeitzer, J.M. Impaired 24-h activity patterns are associated with an increased risk of Alzheimer’s disease, Parkinson’s disease, and cognitive decline. Alzheimer’s Res. Ther. 2024, 16, 35. [Google Scholar] [CrossRef]
  39. Migueles, J.H.; Cadenas-Sanchez, C.; Ekelund, U.; Delisle Nyström, C.; Mora-Gonzalez, J.; Löf, M.; Labayen, I.; Ruiz, J.R.; Ortega, F.B. Accelerometer Data Collection and Processing Criteria to Assess Physical Activity and Other Outcomes: A Systematic Review and Practical Considerations. Sports Med. 2017, 47, 1821–1845. [Google Scholar] [CrossRef]
  40. Danilenko, K.V.; Stefani, O.; Voronin, K.A.; Mezhakova, M.S.; Petrov, I.M.; Borisenkov, M.F.; Markov, A.A.; Gubin, D.G. Wearable Light-and-Motion Dataloggers for Sleep/Wake Research: A Review. Appl. Sci. 2022, 12, 11794. [Google Scholar] [CrossRef]
  41. Blackwell, T.; Redline, S.; Ancoli-Israel, S.; Schneider, J.L.; Surovec, S.; Johnson, N.L.; Cauley, J.A.; Stone, K.L.; Study of Osteoporotic Fractures Research Group. Comparison of Sleep Parameters from Actigraphy and Polysomnography in Older Women: The SOF Study. Sleep 2008, 31, 283–291. [Google Scholar] [CrossRef] [PubMed]
  42. Quante, M.; Kaplan, E.R.; Cailler, M.; Rueschman, M.; Wang, R.; Weng, J.; Taveras, E.M.; Redline, S. Actigraphy-based sleep estimation in adolescents and adults: A comparison with polysomnography using two scoring algorithms. Nat. Sci. Sleep 2018, 10, 13–20. [Google Scholar] [CrossRef]
  43. Smith, M.T.; McCrae, C.S.; Cheung, J.; Martin, J.L.; Harrod, C.G.; Heald, J.L.; Carden, K.A. Use of Actigraphy for the Evaluation of Sleep Disorders and Circadian Rhythm Sleep-Wake Disorders: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment. J. Clin. Sleep Med. 2018, 14, 1209–1230. [Google Scholar] [CrossRef] [PubMed]
  44. Fekedulegn, D.; Andrew, M.E.; Shi, M.; Violanti, J.M.; Knox, S.; Innes, K.E. Actigraphy-Based Assessment of Sleep Parameters. Ann. Work Expo. Health 2020, 64, 350–367. [Google Scholar] [CrossRef] [PubMed]
  45. Lehrer, H.M.; Yao, Z.; Krafty, R.T.; Evans, M.A.; Buysse, D.J.; Kravitz, H.M.; Matthews, K.A.; Gold, E.B.; Harlow, S.D.; Samuelsson, L.B.; et al. Comparing polysomnography, actigraphy, and sleep diary in the home environment: The Study of Women’s Health Across the Nation (SWAN) Sleep Study. SLEEP Adv. 2022, 3, zpac001. [Google Scholar] [CrossRef] [PubMed]
  46. Winnebeck, E.C.; Fischer, D.; Leise, T.; Roenneberg, T. Dynamics and Ultradian Structure of Human Sleep in Real Life. Curr. Biol. 2017, 28, 49–59.e5. [Google Scholar] [CrossRef] [PubMed]
  47. Cajochen, C.; Reichert, C.F.; Münch, M.; Gabel, V.; Stefani, O.; Chellappa, S.L.; Schmidt, C. Ultradian sleep cycles: Frequency, duration, and associations with individual and environmental factors—A retrospective study. Sleep Health 2023, 10, S52–S62. [Google Scholar] [CrossRef] [PubMed]
  48. Witting, W.; Kwa, I.H.; Eikelenboom, P.; Mirmiran, M.; Swaab, D. Alterations in the circadian rest-activity rhythm in aging and Alzheimer’s disease. Biol. Psychiatry 1990, 27, 563–572. [Google Scholar] [CrossRef]
  49. Van Someren, E.J.W.; Swaab, D.F.; Colenda, C.C.; Cohen, W.; McCall, W.V.; Rosenquist, P.B. Bright Light Therapy: Improved Sensitivity to Its Effects on Rest-Activity Rhythms in Alzheimer Patients by Application of Nonparametric Methods. Chronobiol. Int. 1999, 16, 505–518. [Google Scholar] [CrossRef] [PubMed]
  50. Ortiz-Tudela, E.; Martinez-Nicolas, A.; Campos, M.; Rol, M.Á.; Madrid, J.A. A New Integrated Variable Based on Thermometry, Actimetry and Body Position (TAP) to Evaluate Circadian System Status in Humans. PLoS Comput. Biol. 2010, 6, e1000996. [Google Scholar] [CrossRef] [PubMed]
  51. Borisenkov, M.; Tserne, T.; Bakutova, L.; Gubin, D. Actimetry-Derived 24 h Rest–Activity Rhythm Indices Applied to Predict MCTQ and PSQI. Appl. Sci. 2022, 12, 6888. [Google Scholar] [CrossRef]
  52. Danilevicz, I.M.; van Hees, V.T.; van der Heide, F.C.T.; Jacob, L.; Landré, B.; Benadjaoud, M.A.; Sabia, S. Measures of fragmentation of rest activity patterns: Mathematical properties and interpretability based on accelerometer real life data. BMC Med. Res. Methodol. 2024, 24, 132. [Google Scholar] [CrossRef] [PubMed]
  53. Gubin, D.; Danilenko, K.; Stefani, O.; Kolomeichuk, S.; Markov, A.; Petrov, I.; Voronin, K.; Mezhakova, M.; Borisenkov, M.; Shigabaeva, A.; et al. Blue Light and Temperature Actigraphy Measures Predicting Metabolic Health Are Linked to Melatonin Receptor Polymorphism. Biology 2023, 13, 22. [Google Scholar] [CrossRef] [PubMed]
  54. Spira, A.P.; Liu, F.; Zipunnikov, V.; Bilgel, M.; Rabinowitz, J.A.; An, Y.; Di, J.; Bai, J.; Wanigatunga, S.K.; Wu, M.N.; et al. Evaluating a novel 24-hour rest/activity rhythm marker of preclinical β-amyloid deposition. Sleep 2024, 47, zsae037. [Google Scholar] [CrossRef]
  55. Blackwell, T.L.; Figueiro, M.G.; Tranah, G.J.; Zeitzer, J.M.; Yaffe, K.; Ancoli-Israel, S.; Kado, D.M.; Ensrud, K.E.; Lane, N.E.; Leng, Y.; et al. Associations of 24-Hour Light Exposure and Activity Patterns and Risk of Cognitive Impairment and Decline in Older Men: The MrOS Sleep Study. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2022, 78, 1834–1843. [Google Scholar] [CrossRef]
  56. Xiao, Q.; Durbin, J.; Bauer, C.; Yeung, C.H.C.; Figueiro, M.G. Alignment Between 24-h Light-Dark and Activity-Rest Rhythms Is Associated with Diabetes and Glucose Metabolism in a Nationally Representative Sample of American Adults. Diabetes Care 2023, 46, 2171–2179. [Google Scholar] [CrossRef]
  57. Zimmet, P.; Alberti, K.G.M.M.; Stern, N.; Bilu, C.; El-Osta, A.; Einat, H.; Kronfeld-Schor, N. The Circadian Syndrome: Is the Metabolic Syndrome and much more! J. Intern. Med. 2019, 286, 181–191. [Google Scholar] [CrossRef] [PubMed]
  58. Shi, Z.; Tuomilehto, J.; Kronfeld-Schor, N.; Alberti, G.; Stern, N.; El-Osta, A.; Chai, Z.; Bilu, C.; Einat, H.; Zimmet, P. The Circadian Syndrome Is a Significant and Stronger Predictor for Cardiovascular Disease than the Metabolic Syndrome—The NHANES Survey during 2005–2016. Nutrients 2022, 14, 5317. [Google Scholar] [CrossRef] [PubMed]
  59. Whitaker, K.M.; Lutsey, P.L.; Ogilvie, R.P.; Pankow, J.S.; Bertoni, A.; Michos, E.D.; Punjabi, N.; Redline, S. Associations between polysomnography and actigraphy-based sleep indices and glycemic control among those with and without type 2 diabetes: The Multi-Ethnic Study of Atherosclerosis. Sleep 2018, 41, zsy172. [Google Scholar] [CrossRef] [PubMed]
  60. Huang, T.; Redline, S. Cross-sectional and Prospective Associations of Actigraphy-Assessed Sleep Regularity with Metabolic Abnormalities: The Multi-Ethnic Study of Atherosclerosis. Diabetes Care 2019, 42, 1422–1429. [Google Scholar] [CrossRef] [PubMed]
  61. Xiao, Q.; Qian, J.; Evans, D.S.; Redline, S.; Lane, N.E.; Ancoli-Israel, S.; Scheer, F.A.; Stone, K.; Osteoporotic Fractures in Men (MrOS) Study Group. Cross-sectional and Prospective Associations of Rest-Activity Rhythms with Metabolic Markers and Type 2 Diabetes in Older Men. Diabetes Care 2020, 43, 2702–2712. [Google Scholar] [CrossRef]
  62. Xiao, Q.; Matthews, C.E.; Playdon, M.; Bauer, C. The association between rest-activity rhythms and glycemic markers: The US National Health and Nutrition Examination Survey, 2011–2014. Sleep 2021, 45, zsab291. [Google Scholar] [CrossRef] [PubMed]
  63. Kim, M.; Vu, T.-H.; Maas, M.B.; Braun, R.I.; Wolf, M.S.; Roenneberg, T.; Daviglus, M.L.; Reid, K.J.; Zee, P.C. Light at night in older age is associated with obesity, diabetes, and hypertension. Sleep 2022, 46, zsac130. [Google Scholar] [CrossRef] [PubMed]
  64. Wallace, D.A.; Qiu, X.; Schwartz, J.; Huang, T.; Scheer, F.A.; Redline, S.; Sofer, T. Light exposure during sleep is bidirectionally associated with irregular sleep timing: The multi-ethnic study of atherosclerosis (MESA). Environ. Pollut. 2023, 344, 123258. [Google Scholar] [CrossRef] [PubMed]
  65. Gubin, G.D.; Weinert, D. Bioritmy i vozrast [Biorhythms and age]. Usp Fiziol Nauk. 1991, 22, 77–96. (In Russian) [Google Scholar] [PubMed]
  66. Gubin, D.; Cornélissen, G.; Halberg, F.; Gubin, G.; Uezono, K.; Kawasaki, T. The human blood pressure chronome: A biological gauge of aging. In Vivo 1998, 11, 485–494. [Google Scholar]
  67. Abbott, S.M.; Malkani, R.G.; Zee, P.C. Circadian disruption and human health: A bidirectional relationship. Eur. J. Neurosci. 2019, 51, 567–583. [Google Scholar] [CrossRef]
  68. Xu, Y.; Wang, X.; Belsky, D.W.; McCall, W.V.; Liu, Y.; Su, S. Blunted Rest–Activity Circadian Rhythm is Associated with Increased Rate of Biological Aging: An Analysis of NHANES 2011–2014. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2022, 78, 407–413. [Google Scholar] [CrossRef] [PubMed]
  69. Gubin, D.G.; Malishevskaya, T.N.; Astakhov, Y.S.; Astakhov, S.Y.; Cornelissen, G.; Kuznetsov, V.A.; Weinert, D. Progressive retinal ganglion cell loss in primary open-angle glaucoma is associated with temperature circadian rhythm phase delay and compromised sleep. Chronobiol. Int. 2019, 36, 564–577. [Google Scholar] [CrossRef]
  70. Lyall, L.M.; Wyse, C.A.; Graham, N.; Ferguson, A.; Lyall, D.M.; Cullen, B.; Morales, C.A.C.; Biello, S.M.; Mackay, D.; Ward, J.; et al. Association of disrupted circadian rhythmicity with mood disorders, subjective wellbeing, and cognitive function: A cross-sectional study of 91 105 participants from the UK Biobank. Lancet Psychiatry 2018, 5, 507–514. [Google Scholar] [CrossRef] [PubMed]
  71. Feng, H.; Yang, L.; Ai, S.; Liu, Y.; Zhang, W.; Lei, B.; Chen, J.; Liu, Y.; Chan, J.W.Y.; Chan, N.Y.; et al. Association between accelerometer-measured amplitude of rest–activity rhythm and future health risk: A prospective cohort study of the UK Biobank. Lancet Healthy Longev. 2023, 4, e200–e210. [Google Scholar] [CrossRef]
  72. Cai, R.; Gao, L.; Gao, C.; Yu, L.; Zheng, X.; Bennett, D.A.; Buchman, A.S.; Hu, K.; Li, P. Circadian disturbances and frailty risk in older adults. Nat. Commun. 2023, 14, 7219. [Google Scholar] [CrossRef]
  73. Brooks, T.G.; Lahens, N.F.; Grant, G.R.; Sheline, Y.I.; FitzGerald, G.A.; Skarke, C. Diurnal rhythms of wrist temperature are associated with future disease risk in the UK Biobank. Nat. Commun. 2023, 14, 5172. [Google Scholar] [CrossRef] [PubMed]
  74. Xu, Y.; Su, S.; McCall, W.V.; Isales, C.; Snieder, H.; Wang, X. Rest-activity circadian rhythm and impaired glucose tolerance in adults: An analysis of NHANES 2011–2014. BMJ Open Diabetes Res. Care 2022, 10, e002632. [Google Scholar] [CrossRef] [PubMed]
  75. Xu, Y.; Su, S.; McCall, W.V.; Wang, X. Blunted rest-activity rhythm is associated with increased white blood-cell-based inflammatory markers in adults: An analysis from NHANES 2011–2014. Chronobiol. Int. 2022, 39, 895–902. [Google Scholar] [CrossRef]
  76. Shim, J.; Fleisch, E.; Barata, F. Wearable-based accelerometer activity profile as digital biomarker of inflammation, biological age, and mortality using hierarchical clustering analysis in NHANES 2011–2014. Sci. Rep. 2023, 13, 9326. [Google Scholar] [CrossRef]
  77. Tai, Y.; Obayashi, K.; Yamagami, Y.; Saeki, K. Association between circadian skin temperature rhythms and actigraphic sleep measures in real-life settings. J. Clin. Sleep Med. 2023, 19, 1281–1292. [Google Scholar] [CrossRef] [PubMed]
  78. Gubin, D.G.; Nelaeva, A.A.; Uzhakova, A.E.; Hasanova, Y.V.; Cornelissen, G.; Weinert, D. Disrupted circadian rhythms of body temperature, heart rate and fasting blood glucose in prediabetes and type 2 diabetes mellitus. Chronobiol. Int. 2017, 34, 1136–1148. [Google Scholar] [CrossRef]
  79. Windred, D.P.; Burns, A.C.; Rutter, M.K.; Yeung, C.H.C.; Lane, J.M.; Xiao, Q.; Saxena, R.; Cain, S.W.; Phillips, A.J. Personal light exposure patterns and incidence of type 2 diabetes: Analysis of 13 million hours of light sensor data and 670,000 person-years of prospective observation. Lancet Reg. Health Eur. 2024, 42, 100943. [Google Scholar] [CrossRef] [PubMed]
  80. Hori, H.; Koga, N.; Hidese, S.; Nagashima, A.; Kim, Y.; Higuchi, T.; Kunugi, H. 24-h activity rhythm and sleep in depressed outpatients. J. Psychiatr. Res. 2016, 77, 27–34. [Google Scholar] [CrossRef] [PubMed]
  81. Merikanto, I.; Partonen, T.; Paunio, T.; Castaneda, A.E.; Marttunen, M.; Urrila, A.S. Advanced phases and reduced amplitudes are suggested to characterize the daily rest-activity cycles in depressed adolescent boys. Chronobiol. Int. 2017, 34, 967–976. [Google Scholar] [CrossRef] [PubMed]
  82. Minaeva, O.; Booij, S.H.; Lamers, F.; Antypa, N.; Schoevers, R.A.; Wichers, M.; Riese, H. Level and timing of physical activity during normal daily life in depressed and non-depressed individuals. Transl. Psychiatry 2020, 10, 259. [Google Scholar] [CrossRef]
  83. Roveda, E.; Montaruli, A.; Galasso, L.; Pesenti, C.; Bruno, E.; Pasanisi, P.; Cortellini, M.; Rampichini, S.; Erzegovesi, S.; Caumo, A.; et al. Rest-activity circadian rhythm and sleep quality in patients with binge eating disorder. Chronobiol. Int. 2017, 35, 198–207. [Google Scholar] [CrossRef] [PubMed]
  84. Otsuka, K.; Cornélissen, G.; Halberg, F.; Oehlerts, G. Excessive circadian amplitude of blood pressure increases risk of ischaemic stroke and nephropathy. J. Med. Eng. Technol. 1997, 21, 23–30. [Google Scholar] [CrossRef] [PubMed]
  85. Cornélissen, G.; Delcourt, A.; Toussaint, G.; Otsuka, K.; Watanabe, Y.; Siegelova, J.; Fiser, B.; Dusek, J.; Homolka, P.; Kumar, A.; et al. Opportunity of detecting pre-hypertension: Worldwide data on blood pressure overswinging. Biomed. Pharmacother. 2005, 59 (Suppl. S1), S152–S157. [Google Scholar] [CrossRef] [PubMed]
  86. Borer, K.T.; Cornelissen, G.; Halberg, F.; Brook, R.; Rajagopalan, S.; Fay, W. Circadian blood pressure overswinging in a physically fit, normotensive African American woman. Am. J. Hypertens. 2002, 15, 827–830. [Google Scholar] [CrossRef] [PubMed]
  87. Velasquez, M.T.; Beddhu, S.; Nobakht, E.; Rahman, M.; Raj, D.S. Ambulatory Blood Pressure in Chronic Kidney Disease: Ready for Prime Time? Kidney Int. Rep. 2016, 1, 94–104. [Google Scholar] [CrossRef] [PubMed]
  88. Murray, J.M.; Magee, M.; Sletten, T.L.; Gordon, C.; Lovato, N.; Ambani, K.; Bartlett, D.J.; Kennaway, D.J.; Lack, L.C.; Grunstein, R.R.; et al. Light-based methods for predicting circadian phase in delayed sleep–wake phase disorder. Sci. Rep. 2021, 11, 10878. [Google Scholar] [CrossRef] [PubMed]
  89. Tranah, G.J.; Blackwell, T.; Ancoli-Israel, S.; Paudel, M.L.; Ensrud, K.E.; Cauley, J.A.; Redline, S.; Hillier, T.A.; Cummings, S.R.; Stone, K.L.; et al. Circadian Activity Rhythms and Mortality: The Study of Osteoporotic Fractures. J. Am. Geriatr. Soc. 2010, 58, 282–291. [Google Scholar] [CrossRef]
  90. Tranah, G.J.; Ma, T.B.; Stone, K.L.; Ancoli-Israel, S.; Paudel, M.L.; Ensrud, K.; Cauley, J.A.; Redline, S.; Hillier, T.A.; Cummings, S.R.; et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann. Neurol. 2011, 70, 722–732. [Google Scholar] [CrossRef] [PubMed]
  91. Saint-Maurice, P.F.; Freeman, J.R.; Russ, D.; Almeida, J.S.; Shams-White, M.M.; Patel, S.; Wolff-Hughes, D.L.; Watts, E.L.; Loftfield, E.; Hong, H.G.; et al. Associations between actigraphy-measured sleep duration, continuity, and timing with mortality in the UK Biobank. Sleep 2023, 47, zsad312. [Google Scholar] [CrossRef] [PubMed]
  92. Gubin, D.; Neroev, V.; Malishevskaya, T.; Cornelissen, G.; Astakhov, S.Y.; Kolomeichuk, S.; Yuzhakova, N.; Kabitskaya, Y.; Weinert, D. Melatonin mitigates disrupted circadian rhythms, lowers intraocular pressure, and improves retinal ganglion cells function in glaucoma. J. Pineal Res. 2021, 70, e12730. [Google Scholar] [CrossRef]
  93. Nikbakhtian, S.; Reed, A.B.; Obika, B.D.; Morelli, D.; Cunningham, A.C.; Aral, M.; Plans, D. Accelerometer-derived sleep onset timing and cardiovascular disease incidence: A UK Biobank cohort study. Eur. Heart J. Digit. Health 2021, 2, 658–666. [Google Scholar] [CrossRef] [PubMed]
  94. Phillips, A.J.K.; Clerx, W.M.; O’brien, C.S.; Sano, A.; Barger, L.K.; Picard, R.W.; Lockley, S.W.; Klerman, E.B.; Czeisler, C.A. Irregular sleep/wake patterns are associated with poorer academic performance and delayed circadian and sleep/wake timing. Sci. Rep. 2017, 7, 3216. [Google Scholar] [CrossRef]
  95. Schlagintweit, J.; Laharnar, N.; Glos, M.; Zemann, M.; Demin, A.V.; Lederer, K.; Penzel, T.; Fietze, I. Effects of sleep fragmentation and partial sleep restriction on heart rate variability during night. Sci. Rep. 2023, 13, 6202. [Google Scholar] [CrossRef]
  96. Laharnar, N.; Fatek, J.; Zemann, M.; Glos, M.; Lederer, K.; Suvorov, A.V.; Demin, A.V.; Penzel, T.; Fietze, I. A sleep intervention study comparing effects of sleep restriction and fragmentation on sleep and vigilance and the need for recovery. Physiol. Behav. 2019, 215, 112794. [Google Scholar] [CrossRef] [PubMed]
  97. Gubin, D.G.; Gubin, G.D.; Gapon, L.I.; Weinert, D. Daily Melatonin Administration Attenuates Age-Dependent Disturbances of Cardiovascular Rhythms. Curr. Aging Sci. 2015, 9, 5–13. [Google Scholar] [CrossRef]
  98. Qian, X.; Droste, S.K.; Lightman, S.L.; Reul, J.M.H.M.; Linthorst, A.C.E. Circadian and Ultradian Rhythms of Free Glucocorticoid Hormone Are Highly Synchronized between the Blood, the Subcutaneous Tissue, and the Brain. Endocrinology 2012, 153, 4346–4353. [Google Scholar] [CrossRef] [PubMed]
  99. Zhu, B.; Zhang, Q.; Pan, Y.; Mace, E.M.; York, B.; Antoulas, A.C.; Dacso, C.C.; O’malley, B.W. A Cell-Autonomous Mammalian 12 hr Clock Coordinates Metabolic and Stress Rhythms. Cell Metab. 2017, 25, 1305–1319.e9. [Google Scholar] [CrossRef]
  100. Kembro, J.M.; Flesia, A.G.; Acosta-Rodríguez, V.A.; Takahashi, J.S.; Nieto, P.S. Dietary restriction modulates ultradian rhythms and autocorrelation properties in mice behavior. Commun. Biol. 2024, 7, 303. [Google Scholar] [CrossRef]
  101. Grant, A.D.; Newman, M.; Kriegsfeld, L.J. Ultradian rhythms in heart rate variability and distal body temperature anticipate onset of the luteinizing hormone surge. Sci. Rep. 2020, 10, 20378. [Google Scholar] [CrossRef] [PubMed]
  102. Otsuka, K.; Murakami, S.; Okajima, K.; Shibata, K.; Kubo, Y.; Gubin, D.G.; Beaty, L.A.; Cornelissen, G. Appropriate Circadian-Circasemidian Coupling Protects Blood Pressure from Morning Surge and Promotes Human Resilience and Wellbeing. Clin. Interv. Aging 2023, 18, 755–769. [Google Scholar] [CrossRef] [PubMed]
  103. Neroev, V.; Malishevskaya, T.; Weinert, D.; Astakhov, S.; Kolomeichuk, S.; Cornelissen, G.; Kabitskaya, Y.; Boiko, E.; Nemtsova, I.; Gubin, D. Disruption of 24-Hour Rhythm in Intraocular Pressure Correlates with Retinal Ganglion Cell Loss in Glaucoma. Int. J. Mol. Sci. 2020, 22, 359. [Google Scholar] [CrossRef] [PubMed]
  104. Reid, K.J.; Santostasi, G.; Baron, K.G.; Wilson, J.; Kang, J.; Zee, P.C. Timing and Intensity of Light Correlate with Body Weight in Adults. PLoS ONE 2014, 9, e92251. [Google Scholar] [CrossRef]
  105. Iimuro, S.; Imai, E.; Watanabe, T.; Nitta, K.; Akizawa, T.; Matsuo, S.; Makino, H.; Ohashi, Y.; Hishida, A. Hyperbaric area index calculated from ABPM elucidates the condition of CKD patients: The CKD-JAC study. Clin. Exp. Nephrol. 2014, 19, 114–124. [Google Scholar] [CrossRef] [PubMed]
  106. Edgley, K.; Chun, H.-Y.Y.; Whiteley, W.N.; Tsanas, A. New Insights into Stroke from Continuous Passively Collected Temperature and Sleep Data Using Wrist-Worn Wearables. Sensors 2023, 23, 1069. [Google Scholar] [CrossRef] [PubMed]
  107. Roenneberg, T.; Allebrandt, K.V.; Merrow, M.; Vetter, C. Social Jetlag and Obesity. Curr. Biol. 2012, 22, 939–943. [Google Scholar] [CrossRef]
  108. Parsons, M.J.; Moffitt, T.E.; Gregory, A.M.; Goldman-Mellor, S.; Nolan, P.M.; Poulton, R.; Caspi, A. Social jetlag, obesity and metabolic disorder: Investigation in a cohort study. Int. J. Obes. 2015, 39, 842–848. [Google Scholar] [CrossRef]
  109. Wong, P.M.; Hasler, B.P.; Kamarck, T.W.; Muldoon, M.F.; Manuck, S.B. Social Jetlag, Chronotype, and Cardiometabolic Risk. J. Clin. Endocrinol. Metab. 2015, 100, 4612–4620. [Google Scholar] [CrossRef] [PubMed]
  110. Caliandro, R.; Streng, A.A.; van Kerkhof, L.W.M.; van der Horst, G.T.J.; Chaves, I. Social Jetlag and Related Risks for Human Health: A Timely Review. Nutrients 2021, 13, 4543. [Google Scholar] [CrossRef] [PubMed]
  111. Roenneberg, T. How can social jetlag affect health? Nat. Rev. Endocrinol. 2023, 19, 383–384. [Google Scholar] [CrossRef]
  112. Henderson, S.E.M.; Brady, E.M.; Robertson, N. Associations between social jetlag and mental health in young people: A systematic review. Chronobiol. Int. 2019, 36, 1316–1333. [Google Scholar] [CrossRef] [PubMed]
  113. Islam, Z.; Hu, H.; Akter, S.; Kuwahara, K.; Kochi, T.; Eguchi, M.; Kurotani, K.; Nanri, A.; Kabe, I.; Mizoue, T. Social jetlag is associated with an increased likelihood of having depressive symptoms among the Japanese working population: The Furukawa Nutrition and Health Study. Sleep 2019, 43, zsz204. [Google Scholar] [CrossRef]
  114. Qu, Y.; Li, T.; Xie, Y.; Tao, S.; Yang, Y.; Zou, L.; Zhang, D.; Zhai, S.; Tao, F.; Wu, X. Association of chronotype, social jetlag, sleep duration and depressive symptoms in Chinese college students. J. Affect. Disord. 2022, 320, 735–741. [Google Scholar] [CrossRef]
  115. Korman, M.; Tkachev, V.; Reis, C.; Komada, Y.; Kitamura, S.; Gubin, D.; Kumar, V.; Roenneberg, T. COVID-19-mandated social restrictions unveil the impact of social time pressure on sleep and body clock. Sci. Rep. 2020, 10, 22225. [Google Scholar] [CrossRef] [PubMed]
  116. Fischer, D.; Klerman, E.B.; Phillips, A.J.K. Measuring sleep regularity: Theoretical properties and practical usage of existing metrics. Sleep 2021, 44, zsab103. [Google Scholar] [CrossRef] [PubMed]
  117. Stone, J.E.; Postnova, S.; Sletten, T.L.; Rajaratnam, S.M.; Phillips, A.J. Computational approaches for individual circadian phase prediction in field settings. Curr. Opin. Syst. Biol. 2020, 22, 39–51. [Google Scholar] [CrossRef]
  118. Kim, D.W.; Zavala, E.; Kim, J.K. Wearable technology and systems modeling for personalized chronotherapy. Curr. Opin. Syst. Biol. 2020, 21, 9–15. [Google Scholar] [CrossRef]
  119. Brown, L.S.; Hilaire, M.A.S.; McHill, A.W.; Phillips, A.J.K.; Barger, L.K.; Sano, A.; Czeisler, C.A.; Doyle, F.J.; Klerman, E.B. A classification approach to estimating human circadian phase under circadian alignment from actigraphy and photometry data. J. Pineal Res. 2021, 71, e12745. [Google Scholar] [CrossRef]
  120. Mayer, C.; Kim, D.W.; Zhang, M.; Lee, M.P.; Forger, D.B.; Burgess, H.J.; Moon, C. Predicting circadian phase in community-dwelling later-life adults using actigraphy data. J. Sleep Res. 2024, e14425. [Google Scholar] [CrossRef] [PubMed]
  121. Huang, Y.; Mayer, C.; Cheng, P.; Siddula, A.; Burgess, H.J.; Drake, C.; Goldstein, C.; Walch, O.; Forger, D.B. Predicting circadian phase across populations: A comparison of mathematical models and wearable devices. Sleep 2021, 44, zsab126. [Google Scholar] [CrossRef]
  122. Gubin, D.G.; Borisenkov, M.F.; Kolomeichuk, S.N.; Markov, A.A.; Weinert, D.; Cornelissen, G.; Stefani, O. Evaluating circadian light hygiene: Methodology and health implications. Russ. Open Med. J. 2024, 13, e0415. [Google Scholar] [CrossRef]
  123. Gubin, D.; Danilenko, K.; Stefani, O.; Kolomeichuk, S.; Markov, A.; Petrov, I.; Voronin, K.; Mezhakova, M.; Borisenkov, M.; Shigabaeva, A.; et al. Light Environment of Arctic Solstices is Coupled with Melatonin Phase-Amplitude Changes and Decline of Metabolic Health. J. Pineal Res. 2024, 77, e70023. [Google Scholar] [CrossRef] [PubMed]
  124. Phillips, A.J.K.; Vidafar, P.; Burns, A.C.; McGlashan, E.M.; Anderson, C.; Rajaratnam, S.M.W.; Lockley, S.W.; Cain, S.W. High sensitivity and interindividual variability in the response of the human circadian system to evening light. Proc. Natl. Acad. Sci. USA 2019, 116, 12019–12024. [Google Scholar] [CrossRef]
  125. Gubin, D.; Boldyreva, J.; Stefani, O.; Kolomeichuk, S.; Danilova, L.; Shigabaeva, A.; Cornelissen, G.; Weinert, D. Higher vulnerability to poor circadian light hygiene in individuals with a history of COVID-19. Chronobiol. Int. 2025, 1–14. [Google Scholar] [CrossRef] [PubMed]
  126. Shurkevich, N.P.; Vetoshkin, A.S.; Kareva, M.A.; Gubin, D.G. Arterial hypertension and COVID-19 in Arctic rotating shift work: The impact of chronostructure disruptions on circadian blood pressure rhythm in relation to echocardiographic parameters. Russ. Open Med. J. 2024, 13, e0408. [Google Scholar] [CrossRef]
  127. Mitchell, J.A.; Quante, M.; Godbole, S.; James, P.; Hipp, J.A.; Marinac, C.R.; Mariani, S.; Feliciano, E.M.C.; Glanz, K.; Laden, F.; et al. Variation in actigraphy-estimated rest-activity patterns by demographic factors. Chronobiol. Int. 2017, 34, 1042–1056. [Google Scholar] [CrossRef] [PubMed]
  128. Hirten, R.P.; Danieletto, M.; Tomalin, L.; Choi, K.H.; Zweig, M.; Golden, E.; Kaur, S.; Helmus, D.; Biello, A.; Pyzik, R.; et al. Use of Physiological Data from a Wearable Device to Identify SARS-CoV-2 Infection and Symptoms and Predict COVID-19 Diagnosis: Observational Study. J. Med. Internet Res. 2021, 23, e26107. [Google Scholar] [CrossRef]
  129. Doyle, M.M.; Murphy, T.E.; Miner, B.; Pisani, M.A.; Lusczek, E.R.; Knauert, M.P. Enhancing cosinor analysis of circadian phase markers using the gamma distribution. Sleep Med. 2022, 92, 1–3. [Google Scholar] [CrossRef] [PubMed]
  130. Gombert-Labedens, M.; Alzueta, E.; Perez-Amparan, E.; Yuksel, D.; Kiss, O.; de Zambotti, M.; Simon, K.; Zhang, J.; Shuster, A.; Morehouse, A.; et al. Using Wearable Skin Temperature Data to Advance Tracking and Characterization of the Menstrual Cycle in a Real-World Setting. J. Biol. Rhythm. 2024, 39, 331–350. [Google Scholar] [CrossRef] [PubMed]
  131. Shim, J.; Fleisch, E.; Barata, F. Circadian rhythm analysis using wearable-based accelerometry as a digital biomarker of aging and healthspan. npj Digit. Med. 2024, 7, 146. [Google Scholar] [CrossRef] [PubMed]
  132. Cole, R.J.; Kripke, D.F.; Gruen, W.; Mullaney, D.J.; Gillin, J.C. Automatic Sleep/Wake Identification From Wrist Activity. Sleep 1992, 15, 461–469. [Google Scholar] [CrossRef]
  133. Sazonov, E.; Sazonova, N.; Schuckers, S.; Neuman, M.; CHIME Study Group. Activity-based sleep–wake identification in infants. Physiol. Meas. 2004, 25, 1291–1304. [Google Scholar] [CrossRef]
  134. Kolodyazhniy, V.; Späti, J.; Frey, S.; Götz, T.; Wirz-Justice, A.; Kräuchi, K.; Cajochen, C.; Wilhelm, F.H. An Improved Method for Estimating Human Circadian Phase Derived From Multichannel Ambulatory Monitoring and Artificial Neural Networks. Chronobiol. Int. 2012, 29, 1078–1097. [Google Scholar] [CrossRef]
  135. Stone, J.E.; Aubert, X.L.; Maass, H.; Phillips, A.J.K.; Magee, M.; Howard, M.E.; Lockley, S.W.; Rajaratnam, S.M.W.; Sletten, T.L. Application of a Limit-Cycle Oscillator Model for Prediction of Circadian Phase in Rotating Night Shift Workers. Sci. Rep. 2019, 9, 11032. [Google Scholar] [CrossRef]
  136. Dijk, D.-J.; Duffy, J.F. Novel Approaches for Assessing Circadian Rhythmicity in Humans: A Review. J. Biol. Rhythm. 2020, 35, 421–438. [Google Scholar] [CrossRef] [PubMed]
  137. Cheng, P.; Walch, O.; Huang, Y.; Mayer, C.; Sagong, C.; Castelan, A.C.; Burgess, H.J.; Roth, T.; Forger, D.B.; Drake, C.L. Predicting circadian misalignment with wearable technology: Validation of wrist-worn actigraphy and photometry in night shift workers. Sleep 2020, 44, zsaa180. [Google Scholar] [CrossRef]
  138. Kim, D.W.; Mayer, C.; Lee, M.P.; Choi, S.W.; Tewari, M.; Forger, D.B. Efficient assessment of real-world dynamics of circadian rhythms in heart rate and body temperature from wearable data. J. R. Soc. Interface 2023, 20, 20230030. [Google Scholar] [CrossRef]
  139. Neikrug, A.B.; Chen, I.Y.; Palmer, J.R.; McCurry, S.M.; Von Korff, M.; Perlis, M.; Vitiello, M.V. Characterizing Behavioral Activity Rhythms in Older Adults Using Actigraphy. Sensors 2020, 20, 549. [Google Scholar] [CrossRef] [PubMed]
  140. Werkmann, V.; Glynn, N.W.; Harezlak, J. Extracting actigraphy-based walking features with structured functional principal components. Physiol. Meas. 2024, 45, 085001. [Google Scholar] [CrossRef] [PubMed]
  141. George, S.V.; Kunkels, Y.K.; Booij, S.; Wichers, M. Uncovering complexity details in actigraphy patterns to differentiate the depressed from the non-depressed. Sci. Rep. 2021, 11, 13447. [Google Scholar] [CrossRef] [PubMed]
  142. Vuong, T.H.; Doan, T.; Takasu, A. Deep Wavelet Convolutional Neural Networks for Multimodal Human Activity Recognition Using Wearable Inertial Sensors. Sensors 2023, 23, 9721. [Google Scholar] [CrossRef] [PubMed]
  143. Ahmed, N.; Al Numan, O.; Kabir, R.; Islam, R.; Watanobe, Y. A Robust Deep Feature Extraction Method for Human Activity Recognition Using a Wavelet Based Spectral Visualisation Technique. Sensors 2024, 24, 4343. [Google Scholar] [CrossRef] [PubMed]
  144. Xu, H.; Liu, J.; Hu, H.; Zhang, Y. Wearable Sensor-Based Human Activity Recognition Method with Multi-Features Extracted from Hilbert-Huang Transform. Sensors 2016, 16, 2048. [Google Scholar] [CrossRef] [PubMed]
  145. Lin, C.-F.; Zhu, J.-D. Hilbert–Huang transformation-based time-frequency analysis methods in biomedical signal applications. Proc. Inst. Mech. Eng. Part H J. Eng. Med. 2012, 226, 208–216. [Google Scholar] [CrossRef] [PubMed]
  146. Zschocke, J.; Kluge, M.; Pelikan, L.; Graf, A.; Glos, M.; Müller, A.; Mikolajczyk, R.; Bartsch, R.P.; Penzel, T.; Kantelhardt, J.W. Detection and analysis of pulse waves during sleep via wrist-worn actigraphy. PLoS ONE 2019, 14, e0226843. [Google Scholar] [CrossRef] [PubMed]
  147. Chen, H.-H.; Lin, C.; Chang, H.-C.; Chang, J.-H.; Chuang, H.-H.; Lin, Y.-H. Developing Methods for Assessing Mental Activity Using Human-Smartphone Interactions: Comparative Analysis of Activity Levels and Phase Patterns in General Mental Activities, Working Mental Activities, and Physical Activities. J. Med. Internet Res. 2024, 26, e56144. [Google Scholar] [CrossRef] [PubMed]
  148. Wei, Y.; Wang, S.; Wang, W.; Lei, X. Using actigraphy to assess chronotype: Simpler is better. Chronobiol. Int. 2024, 41, 1469–1479. [Google Scholar] [CrossRef] [PubMed]
  149. Cribb, L.; Sha, R.; Yiallourou, S.; Grima, N.A.; Cavuoto, M.; Baril, A.-A.; Pase, M.P. Sleep regularity and mortality: A prospective analysis in the UK Biobank. eLife 2023, 12, RP88359. [Google Scholar] [CrossRef] [PubMed]
  150. Najjar, R.P.; Wolf, L.; Taillard, J.; Schlangen, L.J.M.; Salam, A.; Cajochen, C.; Gronfier, C. Chronic Artificial Blue-Enriched White Light is an Effective Countermeasure to Delayed Circadian Phase and Neurobehavioral Decrements. PLoS ONE 2014, 9, e102827. [Google Scholar] [CrossRef] [PubMed]
  151. Baron, K.G.; Reid, K.J. Circadian misalignment and health. Int. Rev. Psychiatry 2014, 26, 139–154. [Google Scholar] [CrossRef] [PubMed]
  152. Potter, G.D.M.; Skene, D.J.; Arendt, J.; Cade, J.E.; Grant, P.J.; Hardie, L.J. Circadian Rhythm and Sleep Disruption: Causes, Metabolic Consequences, and Countermeasures. Endocr. Rev. 2016, 37, 584–608. [Google Scholar] [CrossRef] [PubMed]
  153. Blume, C.; Garbazza, C.; Spitschan, M. Effects of light on human circadian rhythms, sleep and mood. Somnologie 2019, 23, 147–156. [Google Scholar] [CrossRef] [PubMed]
  154. Gubin, D.; Weinert, D. Melatonin, circadian rhythms and glaucoma: Current perspective. Neural Regen. Res. 2022, 17, 1759–1760. [Google Scholar] [CrossRef] [PubMed]
  155. Gubin, D.; Malishevskaya, T.; Weinert, D.; Zakharova, E.; Astakhov, S.; Cornelissen, G. Circadian Disruption in Glaucoma: Causes, Consequences, and Countermeasures. Front. Biosci. 2024, 29, 410. [Google Scholar] [CrossRef] [PubMed]
  156. Albrecht, U. Timing to Perfection: The Biology of Central and Peripheral Circadian Clocks. Neuron 2012, 74, 246–260. [Google Scholar] [CrossRef] [PubMed]
  157. Foster, R.G. Sleep, circadian rhythms and health. Interface Focus 2020, 10, 20190098. [Google Scholar] [CrossRef] [PubMed]
  158. Gubin, D.G.; Kolomeichuk, S.N.; Weinert, D. Circadian clock precision, health, and longevity. J. Chronomed. 2021, 23, 3–15. [Google Scholar] [CrossRef]
  159. Dement, W.; Kleitman, N. Cyclic variations in EEG during sleep and their relation to eye movements, body motility, and dreaming. Electroencephalogr. Clin. Neurophysiol. 1957, 9, 673–690. [Google Scholar] [CrossRef]
  160. Levi, F.; Halberg, F. Circaseptan (about-7-day) bioperiodicity—spontaneous and reactive—and the search for pacemakers. Ric. Clin. Lab. 1982, 12, 323–370. [Google Scholar] [CrossRef] [PubMed]
  161. Coskun, A.; Zarepour, A.; Zarrabi, A. Physiological Rhythms and Biological Variation of Biomolecules: The Road to Personalized Laboratory Medicine. Int. J. Mol. Sci. 2023, 24, 6275. [Google Scholar] [CrossRef]
  162. Madden, K.M.; Feldman, B. Weekly, Seasonal, and Geographic Patterns in Health Contemplations About Sundown Syndrome: An Ecological Correlational Study. JMIR Aging 2019, 2, e13302. [Google Scholar] [CrossRef] [PubMed]
  163. Seizer, L.; Cornélissen-Guillaume, G.; Schiepek, G.K.; Chamson, E.; Bliem, H.R.; Schubert, C. About-Weekly Pattern in the Dynamic Complexity of a Healthy Subject’s Cellular Immune Activity: A Biopsychosocial Analysis. Front. Psychiatry 2022, 13, 799214. [Google Scholar] [CrossRef]
  164. Cornelissen, G.; Hirota, T. Quo Vadis. In Chronobiology and ChronomedicineFrom Molecular and Cellular Mechanisms to Whole Body Interdigitating Networks; Cornelissen, G., Hirota, T., Eds.; Royal Society of Chemistry: London, UK, 2024; Volume 23, Chapter 24; pp. 648–664. [Google Scholar]
  165. Reinberg, A.E.; Dejardin, L.; Smolensky, M.H.; Touitou, Y. Seven-day human biological rhythms: An expedition in search of their origin, synchronization, functional advantage, adaptive value and clinical relevance. Chronobiol. Int. 2016, 34, 162–191. [Google Scholar] [CrossRef]
  166. Cajochen, C.; Altanay-Ekici, S.; Münch, M.; Frey, S.; Knoblauch, V.; Wirz-Justice, A. Evidence that the Lunar Cycle Influences Human Sleep. Curr. Biol. 2013, 23, 1485–1488. [Google Scholar] [CrossRef]
  167. Reinberg, A.; Smolensky, M.H.; Touitou, Y. The full moon as a synchronizer of circa-monthly biological rhythms: Chronobiologic perspectives based on multidisciplinary naturalistic research. Chronobiol. Int. 2016, 33, 465–479. [Google Scholar] [CrossRef] [PubMed]
  168. Hartstein, L.E.; Wright, K.P.; Akacem, L.D.; Behn, C.D.; LeBourgeois, M.K. Evidence of circalunar rhythmicity in young children’s evening melatonin levels. J. Sleep Res. 2022, 32, e13635. [Google Scholar] [CrossRef] [PubMed]
  169. Lunsford-Avery, J.R.; Engelhard, M.M.; Navar, A.M.; Kollins, S.H. Validation of the Sleep Regularity Index in Older Adults and Associations with Cardiometabolic Risk. Sci. Rep. 2018, 8, 14158, Erratum in Sci. Rep. 2020, 10, 2993. https://doi.org/10.1038/s41598-020-59762-1. [Google Scholar] [CrossRef] [PubMed]
  170. Pye, J.; Phillips, A.J.; Cain, S.W.; Montazerolghaem, M.; Mowszowski, L.; Duffy, S.; Hickie, I.B.; Naismith, S.L. Irregular sleep-wake patterns in older adults with current or remitted depression. J. Affect. Disord. 2020, 281, 431–437. [Google Scholar] [CrossRef]
  171. Wong, P.M.; Barker, D.; Roane, B.M.; Van Reen, E.; Carskadon, M.A. Sleep regularity and body mass index: Findings from a prospective study of first-year college students. SLEEP Adv. 2022, 3, zpac004. [Google Scholar] [CrossRef]
  172. Yiallourou, S.R.; Cribb, L.; Cavuoto, M.G.; Rowsthorn, E.; Nicolazzo, J.; Gibson, M.; Baril, A.-A.; Pase, M.P. Association of the Sleep Regularity Index with Incident Dementia and Brain Volume. Neurology 2024, 102, e208029. [Google Scholar] [CrossRef]
  173. Van Someren, E.J. More than a marker: Interaction between the circadian regulation of temperature and sleep, age-related changes, and treatment possibilities. Chronobiol. Int. 2000, 17, 313–354. [Google Scholar] [CrossRef]
  174. Gompper, B.; Bromundt, V.; Orgül, S.; Flammer, J.; Kräuchi, K. Phase relationship between skin temperature and sleep-wake rhythms in women with vascular dysregulation and controls under real-life conditions. Chronobiol. Int. 2010, 27, 1778–1796. [Google Scholar] [CrossRef] [PubMed]
  175. Bonmati-Carrion, M.A.; Middleton, B.; Revell, V.; Skene, D.J.; Rol, M.A.; Madrid, J.A. Circadian phase asessment by ambulatory monitoring in humans: Correlation with dim light melatonin onset. Chronobiol. Int. 2013, 31, 37–51. [Google Scholar] [CrossRef]
  176. Reid, K.J. Assessment of Circadian Rhythms. Neurol. Clin. 2019, 37, 505–526. [Google Scholar] [CrossRef]
  177. Stone, J.E.; Phillips, A.J.K.; Ftouni, S.; Magee, M.; Howard, M.; Lockley, S.W.; Sletten, T.L.; Anderson, C.; Rajaratnam, S.M.W.; Postnova, S. Generalizability of A Neural Network Model for Circadian Phase Prediction in Real-World Conditions. Sci. Rep. 2019, 9, 11001. [Google Scholar] [CrossRef] [PubMed]
  178. Wittmann, M.; Dinich, J.; Merrow, M.; Roenneberg, T. Social Jetlag: Misalignment of Biological and Social Time. Chronobiol. Int. 2006, 23, 497–509. [Google Scholar] [CrossRef] [PubMed]
  179. Roenneberg, T.; Pilz, L.K.; Zerbini, G.; Winnebeck, E.C. Chronotype and Social Jetlag: A (Self-) Critical Review. Biology 2019, 8, 54. [Google Scholar] [CrossRef]
  180. Zerbini, G.; Winnebeck, E.C.; Merrow, M. Weekly, seasonal, and chronotype-dependent variation of dim-light melatonin onset. J. Pineal Res. 2021, 70, e12723. [Google Scholar] [CrossRef]
  181. Brown, T.M.; Brainard, G.C.; Cajochen, C.; Czeisler, C.A.; Hanifin, J.P.; Lockley, S.W.; Lucas, R.J.; Münch, M.; O’hagan, J.B.; Peirson, S.N.; et al. Recommendations for daytime, evening, and nighttime indoor light exposure to best support physiology, sleep, and wakefulness in healthy adults. PLoS Biol. 2022, 20, e3001571. [Google Scholar] [CrossRef]
  182. Cornelissen, G.; Halberg, F.; Bakken, E.E.; Singh, R.B.; Otsuka, K.; Tomlinson, B.; Delcourt, A.; Toussaint, G.; Bathina, S.; Schwartzkopff, O.; et al. 100 or 30 years after Janeway or Bartter, Healthwatch helps avoid “flying blind”. Biomed. Pharmacother. 2004, 58 (Suppl. S1), S69–S86. [Google Scholar] [CrossRef] [PubMed]
  183. Halberg, F.; Powell, D.; Otsuka, K.; Watanabe, Y.; Beaty, L.A.; Rosch, P.; Czaplicki, J.; Hillman, D.; Schwartzkopff, O.; Cornelissen, G. Diagnosing vascular variability anomalies, not only MESOR-hypertension. Am. J. Physiol.-Heart Circ. Physiol. 2013, 305, H279–H294. [Google Scholar] [CrossRef] [PubMed]
  184. Jagannath, A.; Taylor, L.; Wakaf, Z.; Vasudevan, S.R.; Foster, R.G. The genetics of circadian rhythms, sleep and health. Hum. Mol. Genet. 2017, 26, R128–R138. [Google Scholar] [CrossRef] [PubMed]
  185. Bacalini, M.G.; Palombo, F.; Garagnani, P.; Giuliani, C.; Fiorini, C.; Caporali, L.; Maserati, M.S.; Capellari, S.; Romagnoli, M.; De Fanti, S.; et al. Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer’s disease and longevity in an Italian population. GeroScience 2021, 44, 881–896. [Google Scholar] [CrossRef] [PubMed]
  186. Gubin, D.; Neroev, V.; Malishevskaya, T.; Kolomeichuk, S.; Cornelissen, G.; Yuzhakova, N.; Vlasova, A.; Weinert, D. Depression scores are associated with retinal ganglion cells loss. J. Affect. Disord. 2023, 333, 290–296. [Google Scholar] [CrossRef]
  187. Gabriel, B.M.; Zierath, J.R. Circadian rhythms and exercise—Re-setting the clock in metabolic disease. Nat. Rev. Endocrinol. 2019, 15, 197–206. [Google Scholar] [CrossRef]
  188. Martin, R.A.; Esser, K.A. Time for Exercise? Exercise and Its Influence on the Skeletal Muscle Clock. J. Biol. Rhythm. 2022, 37, 579–592. [Google Scholar] [CrossRef] [PubMed]
  189. Martin, R.A.; Viggars, M.R.; Esser, K.A. Metabolism and exercise: The skeletal muscle clock takes centre stage. Nat. Rev. Endocrinol. 2023, 19, 272–284. [Google Scholar] [CrossRef]
  190. Rogers-Soeder, T.S.; Blackwell, T.; Yaffe, K.; Ancoli-Israel, S.; Redline, S.; Cauley, J.A.; Ensrud, K.E.; Paudel, M.; Barrett-Connor, E.; LeBlanc, E.; et al. Rest-Activity Rhythms and Cognitive Decline in Older Men: The Osteoporotic Fractures in Men Sleep Study. J. Am. Geriatr. Soc. 2018, 66, 2136–2143. [Google Scholar] [CrossRef] [PubMed]
  191. Harada, K.; Masumoto, K.; Okada, S. Physical Activity Components that Determine Daily Life Satisfaction Among Older Adults: An Intensive Longitudinal Diary Study. Int. J. Behav. Med. 2024. [Google Scholar] [CrossRef] [PubMed]
  192. Roenneberg, T.; Kuehnle, T.; Juda, M.; Kantermann, T.; Allebrandt, K.; Gordijn, M.; Merrow, M. Epidemiology of the human circadian clock. Sleep Med. Rev. 2007, 11, 429–438. [Google Scholar] [CrossRef] [PubMed]
  193. Fischer, D.; Lombardi, D.A.; Marucci-Wellman, H.; Roenneberg, T. Chronotypes in the US—Influence of age and sex. PLoS ONE 2017, 12, e0178782. [Google Scholar] [CrossRef]
  194. Borisenkov, M.; Gubin, D.; Sergey, K. On the issue of adaptive fitness of chronotypes in high latitudes. Biol. Rhythm. Res. 2024, 55, 354–358. [Google Scholar] [CrossRef]
  195. Farabi, S.S.; Quinn, L.; Carley, D.W. Validity of Actigraphy in Measurement of Sleep in Young Adults with Type 1 Diabetes. J. Clin. Sleep Med. 2017, 13, 669–674. [Google Scholar] [CrossRef] [PubMed]
  196. Rao, F.; Xue, T. Circadian-independent light regulation of mammalian metabolism. Nat. Metab. 2024, 6, 1000–1007. [Google Scholar] [CrossRef] [PubMed]
  197. Weinert, D.; Gubin, D. The Impact of Physical Activity on the Circadian System: Benefits for Health, Performance and Wellbeing. Appl. Sci. 2022, 12, 9220. [Google Scholar] [CrossRef]
  198. Zambrano, C.; Garitaonaindia, M.T.; Salmerón, D.; Pérez-Sanz, F.; Tchio, C.; Picinato, M.C.; de Medina, F.S.; Luján, J.; Scheer, F.A.J.L.; Saxena, R.; et al. Melatonin decreases human adipose tissue insulin sensitivity. J. Pineal Res. 2024, 76, e12965. [Google Scholar] [CrossRef] [PubMed]
  199. Weinert, D.; Waterhouse, J. The circadian rhythm of core temperature: Effects of physical activity and aging. Physiol. Behav. 2006, 90, 246–256. [Google Scholar] [CrossRef] [PubMed]
  200. Tranel, H.R.; Schroder, E.A.; England, J.; Black, W.S.; Bush, H.; Hughes, M.E.; Esser, K.A.; Clasey, J.L. Physical activity, and not fat mass is a primary predictor of circadian parameters in young men. Chronobiol. Int. 2015, 32, 832–841. [Google Scholar] [CrossRef]
  201. Rocher, S.D.; Bessot, N.; Sesboüé, B.; Bulla, J.; Davenne, D. Circadian Characteristics of Older Adults and Aerobic Capacity. J. Gerontol. Ser. A 2015, 71, 817–822. [Google Scholar] [CrossRef]
  202. Gubin, D.G.; Weinert, D.; Rybina, S.V.; Danilova, L.A.; Solovieva, S.V.; Durov, A.M.; Prokopiev, N.Y.; Ushakov, P.A. Activity, sleep and ambient light have a different impact on circadian blood pressure, heart rate and body temperature rhythms. Chronobiol. Int. 2017, 34, 632–649. [Google Scholar] [CrossRef] [PubMed]
  203. Borisenkov, M.F.; Tserne, T.A.; Bakutova, L.A.; Gubin, D.G. Food addiction and emotional eating are associated with intradaily rest–activity rhythm variability. Eat. Weight Disord. 2022, 27, 3309–3316. [Google Scholar] [CrossRef]
  204. Healy, K.L.; Morris, A.R.; Liu, A.C. Circadian Synchrony: Sleep, Nutrition, and Physical Activity. Front. Netw. Physiol. 2021, 1, 732243. [Google Scholar] [CrossRef] [PubMed]
  205. Bonekamp, N.E.; May, A.M.; Halle, M.; Dorresteijn, J.A.N.; van der Meer, M.G.; Ruigrok, Y.M.; de Borst, G.J.; Geleijnse, J.M.; Visseren, F.L.J.; Koopal, C. Physical exercise volume, type, and intensity and risk of all-cause mortality and cardiovascular events in patients with cardiovascular disease: A mediation analysis. Eur. Heart J. Open 2023, 3, oead057. [Google Scholar] [CrossRef]
  206. Franczyk, B.; Gluba-Brzózka, A.; Ciałkowska-Rysz, A.; Ławiński, J.; Rysz, J. The Impact of Aerobic Exercise on HDL Quantity and Quality: A Narrative Review. Int. J. Mol. Sci. 2023, 24, 4653. [Google Scholar] [CrossRef] [PubMed]
  207. Liu, H.; Liu, S.; Wang, K.; Zhang, T.; Yin, L.; Liang, J.; Yang, Y.; Luo, J. Time-Dependent Effects of Physical Activity on Cardiovascular Risk Factors in Adults: A Systematic Review. Int. J. Environ. Res. Public Health 2022, 19, 14194. [Google Scholar] [CrossRef] [PubMed]
  208. Schock, S.; Hakim, A. The Physiological and Molecular Links Between Physical Activity and Brain Health: A Review. Neurosci. Insights 2023, 18, 26331055231191523. [Google Scholar] [CrossRef]
  209. Zhang, H.; Liu, J.; Cui, M.; Chai, H.; Chen, L.; Zhang, T.; Mi, J.; Guan, H.; Zhao, L. Moderate-intensity continuous training has time-specific effects on the lipid metabolism of adolescents. J. Transl. Intern. Med. 2023, 11, 57–69. [Google Scholar] [CrossRef] [PubMed]
  210. Kent, B.A.; Rahman, S.A.; Hilaire, M.A.S.; Grant, L.K.; Rüger, M.; Czeisler, C.A.; Lockley, S.W. Circadian lipid and hepatic protein rhythms shift with a phase response curve different than melatonin. Nat. Commun. 2022, 13, 2241. [Google Scholar] [CrossRef] [PubMed]
  211. Gubin, D.; Neroev, V.; Malishevskaya, T.; Kolomeichuk, S.; Weinert, D.; Yuzhakova, N.; Nelaeva, A.; Filippova, Y.; Cornelissen, G. Daytime Lipid Metabolism Modulated by CLOCK Gene Is Linked to Retinal Ganglion Cells Damage in Glaucoma. Appl. Sci. 2022, 12, 6374. [Google Scholar] [CrossRef]
  212. Wei, W.; Raun, S.H.; Long, J.Z. Molecular Insights from Multiomics Studies of Physical Activity. Diabetes 2024, 73, 162–168. [Google Scholar] [CrossRef]
  213. Chen, C.; Nakagawa, S. Physical activity for cognitive health promotion: An overview of the underlying neurobiological mechanisms. Ageing Res. Rev. 2023, 86, 101868. [Google Scholar] [CrossRef] [PubMed]
  214. Phillips, C.M.; Dillon, C.B.; Perry, I.J. Does replacing sedentary behaviour with light or moderate to vigorous physical activity modulate inflammatory status in adults? Int. J. Behav. Nutr. Phys. Act. 2017, 14, 138. [Google Scholar] [CrossRef] [PubMed]
  215. Tsai, C.-L.; Ukropec, J.; Ukropcová, B.; Pai, M.-C. An acute bout of aerobic or strength exercise specifically modifies circulating exerkine levels and neurocognitive functions in elderly individuals with mild cognitive impairment. NeuroImage Clin. 2018, 17, 272–284. [Google Scholar] [CrossRef]
  216. Li, V.L.; He, Y.; Contrepois, K.; Liu, H.; Kim, J.T.; Wiggenhorn, A.L.; Tanzo, J.T.; Tung, A.S.-H.; Lyu, X.; Zushin, P.-J.H.; et al. An exercise-inducible metabolite that suppresses feeding and obesity. Nature 2022, 606, 785–790. [Google Scholar] [CrossRef] [PubMed]
  217. Okauchi, H.; Hashimoto, C.; Nakao, R.; Oishi, K. Timing of food intake is more potent than habitual voluntary exercise to prevent diet-induced obesity in mice. Chronobiol. Int. 2018, 36, 57–74. [Google Scholar] [CrossRef] [PubMed]
  218. Cheng, Q.; Lu, C.; Qian, R. The circadian clock regulates metabolic responses to physical exercise. Chronobiol. Int. 2022, 39, 907–917. [Google Scholar] [CrossRef]
  219. Stanford, K.I.; Lynes, M.D.; Takahashi, H.; Baer, L.A.; Arts, P.J.; May, F.J.; Lehnig, A.C.; Middelbeek, R.J.W.; Richard, J.J.; So, K.; et al. 12,13-diHOME: An Exercise-Induced Lipokine that Increases Skeletal Muscle Fatty Acid Uptake. Cell Metab. 2018, 27, 1111–1120.e3. [Google Scholar] [CrossRef] [PubMed]
  220. Yang, J.; Vamvini, M.; Nigro, P.; Ho, L.-L.; Galani, K.; Alvarez, M.; Tanigawa, Y.; Renfro, A.; Carbone, N.P.; Laakso, M.; et al. Single-cell dissection of the obesity-exercise axis in adipose-muscle tissues implies a critical role for mesenchymal stem cells. Cell Metab. 2022, 34, 1578–1593.e6. [Google Scholar] [CrossRef] [PubMed]
  221. Rey, G.; Valekunja, U.K.; Feeney, K.A.; Wulund, L.; Milev, N.B.; Stangherlin, A.; Ansel-Bollepalli, L.; Velagapudi, V.; O’neill, J.S.; Reddy, A.B. The Pentose Phosphate Pathway Regulates the Circadian Clock. Cell Metab. 2016, 24, 462–473. [Google Scholar] [CrossRef] [PubMed]
  222. Fagiani, F.; Di Marino, D.; Romagnoli, A.; Travelli, C.; Voltan, D.; Mannelli, L.D.C.; Racchi, M.; Govoni, S.; Lanni, C. Molecular regulations of circadian rhythm and implications for physiology and diseases. Signal Transduct. Target. Ther. 2022, 7, 41. [Google Scholar] [CrossRef]
  223. Esteras, N.; Blacker, T.S.; Zherebtsov, E.A.; Stelmashuk, O.A.; Zhang, Y.; Wigley, W.C.; Duchen, M.R.; Dinkova-Kostova, A.T.; Abramov, A.Y. Nrf2 regulates glucose uptake and metabolism in neurons and astrocytes. Redox Biol. 2023, 62, 102672. [Google Scholar] [CrossRef] [PubMed]
  224. Wible, R.S.; Ramanathan, C.; Sutter, C.H.; Olesen, K.M.; Kensler, T.W.; Liu, A.C.; Sutter, T.R.; States, U. NRF2 regulates core and stabilizing circadian clock loops, coupling redox and timekeeping in Mus musculus. eLife 2018, 7, e31656. [Google Scholar] [CrossRef] [PubMed]
  225. Fasipe, B.; Laher, I. Nrf2 modulates the benefits of evening exercise in type 2 diabetes. Sports Med. Health Sci. 2023, 5, 251–258. [Google Scholar] [CrossRef] [PubMed]
  226. Thomas, A.W.; Davies, N.A.; Moir, H.; Watkeys, L.; Ruffino, J.S.; Isa, S.A.; Butcher, L.R.; Hughes, M.G.; Morris, K.; Webb, R. Exercise-associated generation of PPARγ ligands activates PPARγ signaling events and upregulates genes related to lipid metabolism. J. Appl. Physiol. 2012, 112, 806–815. [Google Scholar] [CrossRef]
  227. Chen, L.; Yang, G. PPARs Integrate the Mammalian Clock and Energy Metabolism. PPAR Res. 2014, 2014, 653017. [Google Scholar] [CrossRef] [PubMed]
  228. Yang, X.; Downes, M.; Yu, R.T.; Bookout, A.L.; He, W.; Straume, M.; Mangelsdorf, D.J.; Evans, R.M. Nuclear Receptor Expression Links the Circadian Clock to Metabolism. Cell 2006, 126, 801–810. [Google Scholar] [CrossRef] [PubMed]
  229. Sun, S.; Ma, S.; Cai, Y.; Wang, S.; Ren, J.; Yang, Y.; Ping, J.; Wang, X.; Zhang, Y.; Yan, H.; et al. A single-cell transcriptomic atlas of exercise-induced anti-inflammatory and geroprotective effects across the body. Innovation 2023, 4, 100380. [Google Scholar] [CrossRef] [PubMed]
  230. Matei, D.; Trofin, D.; Iordan, D.A.; Onu, I.; Condurache, I.; Ionite, C.; Buculei, I. The Endocannabinoid System and Physical Exercise. Int. J. Mol. Sci. 2023, 24, 1989. [Google Scholar] [CrossRef] [PubMed]
  231. Nebe, S.; Reutter, M.; Baker, D.H.; Bölte, J.; Domes, G.; Gamer, M.; Gärtner, A.; Gießing, C.; Gurr, C.; Hilger, K.; et al. Enhancing precision in human neuroscience. eLife 2023, 12, e85980. [Google Scholar] [CrossRef] [PubMed]
  232. Muddapu, V.R.; Dharshini, S.A.P.; Chakravarthy, V.S.; Gromiha, M.M. Neurodegenerative Diseases—Is Metabolic Deficiency the Root Cause? Front. Neurosci. 2020, 14, 213. [Google Scholar] [CrossRef] [PubMed]
  233. Procaccini, C.; Santopaolo, M.; Faicchia, D.; Colamatteo, A.; Formisano, L.; de Candia, P.; Galgani, M.; De Rosa, V.; Matarese, G. Role of metabolism in neurodegenerative disorders. Metabolism 2016, 65, 1376–1390. [Google Scholar] [CrossRef]
  234. Breasail, M.Ó.; Biswas, B.; Smith, M.D.; Mazhar, K.A.; Tenison, E.; Cullen, A.; Lithander, F.E.; Roudaut, A.; Henderson, E.J. Wearable GPS and Accelerometer Technologies for Monitoring Mobility and Physical Activity in Neurodegenerative Disorders: A Systematic Review. Sensors 2021, 21, 8261. [Google Scholar] [CrossRef]
  235. Cote, A.C.; Phelps, R.J.; Kabiri, N.S.; Bhangu, J.S.; Thomas, K. Evaluation of Wearable Technology in Dementia: A Systematic Review and Meta-Analysis. Front. Med. 2021, 7, 501104. [Google Scholar] [CrossRef] [PubMed]
  236. Nussbaumer-Streit, B.; Forneris, C.A.; Morgan, L.C.; Van Noord, M.G.; Gaynes, B.N.; Greenblatt, A.; Wipplinger, J.; Lux, L.J.; Winkler, D.; Gartlehner, G. Light therapy for preventing seasonal affective disorder. Cochrane Database Syst. Rev. 2019, 2019, CD011269. [Google Scholar] [CrossRef] [PubMed]
  237. Liu, Y.-L.; Gong, S.-Y.; Xia, S.-T.; Wang, Y.-L.; Peng, H.; Shen, Y.; Liu, C.-F. Light therapy: A new option for neurodegenerative diseases. Chin. Med. J. 2020, 134, 634–645. [Google Scholar] [CrossRef] [PubMed]
  238. Cardinali, D.P. Melatonin: Clinical Perspectives in Neurodegeneration. Front. Endocrinol. 2019, 10, 480. [Google Scholar] [CrossRef] [PubMed]
  239. Won, E.; Na, K.-S.; Kim, Y.-K. Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression. Int. J. Mol. Sci. 2021, 23, 305. [Google Scholar] [CrossRef] [PubMed]
  240. Shin, J.-W. Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases. Encephalitis 2023, 3, 44–53. [Google Scholar] [CrossRef]
  241. Chen, Y.; Tan, J.; Liu, Y.; Dong, G.-H.; Yang, B.-Y.; Li, N.; Wang, L.; Chen, G.; Li, S.; Guo, Y. Long-term exposure to outdoor light at night and mild cognitive impairment: A nationwide study in Chinese veterans. Sci. Total. Environ. 2022, 847, 157441. [Google Scholar] [CrossRef]
  242. Mazzoleni, E.; Vinceti, M.; Costanzini, S.; Garuti, C.; Adani, G.; Vinceti, G.; Zamboni, G.; Tondelli, M.; Galli, C.; Salemme, S.; et al. Outdoor artificial light at night and risk of early-onset dementia: A case-control study in the Modena population, Northern Italy. Heliyon 2023, 9, e17837. [Google Scholar] [CrossRef] [PubMed]
  243. Volicer, L.; Harper, D.G.; Manning, B.C.; Goldstein, R.; Satlin, A. Sundowning and Circadian Rhythms in Alzheimer’s Disease. Am. J. Psychiatry 2001, 158, 704–711. [Google Scholar] [CrossRef] [PubMed]
  244. Canevelli, M.; Valletta, M.; Trebbastoni, A.; Sarli, G.; D’antonio, F.; Tariciotti, L.; de Lena, C.; Bruno, G. Sundowning in Dementia: Clinical Relevance, Pathophysiological Determinants, and Therapeutic Approaches. Front. Med. 2016, 3, 73. [Google Scholar] [CrossRef] [PubMed]
  245. Blasi, M.T.; Valletta, M.; Trebbastoni, A.; D’antonio, F.; Talarico, G.; Campanelli, A.; Monti, M.S.; Salati, E.; Gasparini, M.; Buscarnera, S.; et al. Sundowning in Patients with Dementia: Identification, Prevalence, and Clinical Correlates. J. Alzheimer’s Dis. 2023, 94, 601–610. [Google Scholar] [CrossRef] [PubMed]
  246. Feng, R.; Li, L.; Yu, H.; Liu, M.; Zhao, W. Melanopsin retinal ganglion cell loss and circadian dysfunction in Alzheimer’s disease (Review). Mol. Med. Rep. 2016, 13, 3397–3400. [Google Scholar] [CrossRef] [PubMed]
  247. La Morgia, C.; Ross-Cisneros, F.N.; Koronyo, Y.; Hannibal, J.; Gallassi, R.; Cantalupo, G.; Sambati, L.; Pan, B.X.; Tozer, K.R.; Barboni, P.; et al. Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann. Neurol. 2015, 79, 90–109. [Google Scholar] [CrossRef] [PubMed]
  248. Shen, Y.; Lv, Q.-K.; Xie, W.-Y.; Gong, S.-Y.; Zhuang, S.; Liu, J.-Y.; Mao, C.-J.; Liu, C.-F. Circadian disruption and sleep disorders in neurodegeneration. Transl. Neurodegener. 2023, 12, 8. [Google Scholar] [CrossRef]
  249. Gracitelli, C.P.; Duque-Chica, G.L.; Roizenblatt, M.; Moura, A.L.; Nagy, B.V.; Ragot de Melo, G.; Borba, P.D.; Teixeira, S.H.; Tufik, S.; Ventura, D.F.; et al. Intrinsically photosensitive retinal ganglion cell activity is associated with decreased sleep quality in patients with glaucoma. Ophthalmology 2015, 122, 1139–1148. [Google Scholar] [CrossRef]
  250. Mahanna-Gabrielli, E.; Kuwayama, S.; Tarraf, W.; Kaur, S.; DeBuc, D.C.; Cai, J.; Daviglus, M.L.; Joslin, C.E.; Lee, D.J.; Mendoza-Santiesteban, C.; et al. The Effect of Self-Reported Visual Impairment and Sleep on Cognitive Decline: Results of the Hispanic Community Health Study/Study of Latinos. J. Alzheimer’s Dis. 2023, 92, 1257–1267. [Google Scholar] [CrossRef] [PubMed]
  251. Kawasaki, A.; Udry, M.; El Wardani, M.; Münch, M. Can Extra Daytime Light Exposure Improve Well-Being and Sleep? A Pilot Study of Patients with Glaucoma. Front. Neurol. 2021, 11, 584479. [Google Scholar] [CrossRef]
  252. Chellappa, S.L.; Bromundt, V.; Frey, S.; Schlote, T.; Goldblum, D.; Cajochen, C. Cross-sectional study of intraocular cataract lens replacement, circadian rest–activity rhythms, and sleep quality in older adults. Sleep 2022, 45, zsac027. [Google Scholar] [CrossRef] [PubMed]
  253. Gubin, D.; Boldyreva, J.; Stefani, O.; Kolomeichuk, S.; Danilova, L.; Markov, A.; Shigabaeva, A.; Cornelissen, G.; Weinert, D. Light exposure predicts COVID-19 negative status in young adults. Biol. Rhythm. Res. 2024, 55, 1–12. [Google Scholar] [CrossRef]
  254. Shen, B.; Ma, C.; Wu, G.; Liu, H.; Chen, L.; Yang, G. Effects of exercise on circadian rhythms in humans. Front. Pharmacol. 2023, 14, 1282357. [Google Scholar] [CrossRef]
  255. Weinert, D.; Schöttner, K.; Müller, L.; Wienke, A. Intensive voluntary wheel running may restore circadian activity rhythms and improves the impaired cognitive performance of arrhythmic Djungarian hamsters. Chronobiol. Int. 2016, 33, 1161–1170. [Google Scholar] [CrossRef]
  256. Weinert, D.; Weinandy, R.; Gattermann, R. Photic and non-photic effects on the daily activity pattern of Mongolian gerbils. Physiol. Behav. 2007, 90, 325–333. [Google Scholar] [CrossRef] [PubMed]
  257. Müller, L.; Fritzsche, P.; Weinert, D. Novel object recognition of Djungarian hamsters depends on circadian time and rhythmic phenotype. Chronobiol. Int. 2014, 32, 458–467. [Google Scholar] [CrossRef] [PubMed]
  258. Müller, L.; Weinert, D. Individual recognition of social rank and social memory performance depends on a functional circadian system. Behav. Process. 2016, 132, 85–93. [Google Scholar] [CrossRef]
  259. Iwayama, K.; Seol, J.; Tokuyama, K. Exercise Timing Matters for Glycogen Metabolism and Accumulated Fat Oxidation over 24 h. Nutrients 2023, 15, 1109. [Google Scholar] [CrossRef] [PubMed]
  260. Arciero, P.J.; Ives, S.J.; Mohr, A.E.; Robinson, N.; Escudero, D.; Robinson, J.; Rose, K.; Minicucci, O.; O’brien, G.; Curran, K.; et al. Morning Exercise Reduces Abdominal Fat and Blood Pressure in Women; Evening Exercise Increases Muscular Performance in Women and Lowers Blood Pressure in Men. Front. Physiol. 2022, 13, 893783. [Google Scholar] [CrossRef] [PubMed]
  261. Hodgson, N.A.; McPhillips, M.V.; Petrovsky, D.V.; Perez, A.; Talwar, S.; Gooneratne, N.; Riegel, B.; Aryal, S.; Gitlin, L.N. Timed Activity to Minimize Sleep Disturbance in People with Cognitive Impairment. Innov. Aging 2023, 8, igad132. [Google Scholar] [CrossRef] [PubMed]
  262. Seo, D.Y.; Lee, S.; Kim, N.; Ko, K.S.; Rhee, B.D.; Park, B.J.; Han, J. Morning and evening exercise. Integr. Med. Res. 2013, 2, 139–144. [Google Scholar] [CrossRef]
  263. Smith, P.J.; Merwin, R.M. The Role of Exercise in Management of Mental Health Disorders: An Integrative Review. Annu. Rev. Med. 2021, 72, 45–62. [Google Scholar] [CrossRef] [PubMed]
  264. Youngstedt, S.D.; Elliott, J.A.; Kripke, D.F. Human circadian phase–response curves for exercise. J. Physiol. 2019, 597, 2253–2268. [Google Scholar] [CrossRef] [PubMed]
  265. Liang, Y.Y.; Feng, H.; Chen, Y.; Jin, X.; Xue, H.; Zhou, M.; Ma, H.; Ai, S.; Wing, Y.-K.; Geng, Q.; et al. Joint association of physical activity and sleep duration with risk of all-cause and cause-specific mortality: A population-based cohort study using accelerometry. Eur. J. Prev. Cardiol. 2023, 30, 832–843. [Google Scholar] [CrossRef] [PubMed]
  266. Jin, X.; Chen, Y.; Feng, H.; Zhou, M.; Chan, J.W.; Liu, Y.; Kong, A.P.S.; Tan, X.; Wing, Y.-K.; Liang, Y.Y.; et al. Association of accelerometer-measured sleep duration and different intensities of physical activity with incident type 2 diabetes in a population-based cohort study. J. Sport Health Sci. 2023, 13, 222–232. [Google Scholar] [CrossRef]
  267. Ahn, H.-J.; Choi, E.-K.; Rhee, T.-M.; Choi, J.; Lee, K.-Y.; Kwon, S.; Lee, S.-R.; Oh, S.; Lip, G.Y.H. Accelerometer-derived physical activity and the risk of death, heart failure, and stroke in patients with atrial fibrillation: A prospective study from UK Biobank. Br. J. Sports Med. 2024, 58, 427–434. [Google Scholar] [CrossRef] [PubMed]
  268. Stamatakis, E.; Ahmadi, M.N.; Friedenreich, C.M.; Blodgett, J.M.; Koster, A.; Holtermann, A.; Atkin, A.; Rangul, V.; Sherar, L.B.; Teixeira-Pinto, A.; et al. Vigorous Intermittent Lifestyle Physical Activity and Cancer Incidence Among Nonexercising Adults. JAMA Oncol. 2023, 9, 1255–1259. [Google Scholar] [CrossRef] [PubMed]
  269. Khurshid, S.; Al-Alusi, M.A.; Churchill, T.W.; Guseh, J.S.; Ellinor, P.T. Accelerometer-Derived “Weekend Warrior” Physical Activity and Incident Cardiovascular Disease. JAMA 2023, 330, 247–252. [Google Scholar] [CrossRef] [PubMed]
  270. Lin, F.; Lin, Y.; Chen, L.; Huang, T.; Lin, T.; He, J.; Lu, X.; Chen, X.; Wang, Y.; Ye, Q.; et al. Association of physical activity pattern and risk of Parkinson’s disease. npj Digit. Med. 2024, 7, 137. [Google Scholar] [CrossRef]
  271. Ramakrishnan, R.; Doherty, A.; Smith-Byrne, K.; Rahimi, K.; Bennett, D.; Woodward, M.; Walmsley, R.; Dwyer, T. Accelerometer measured physical activity and the incidence of cardiovascular disease: Evidence from the UK Biobank cohort study. PLoS Med. 2021, 18, e1003487, Erratum in PLoS Med. 2021, 18, e1003809. [Google Scholar] [CrossRef]
  272. Shreves, A.H.; Small, S.R.; Travis, R.C.; Matthews, C.E.; Doherty, A. Dose-response of accelerometer-measured physical activity, step count, and cancer risk in the UK Biobank: A prospective cohort analysis. Lancet 2023, 402 (Suppl. S1), S83. [Google Scholar] [CrossRef] [PubMed]
  273. Watts, E.L.; Saint-Maurice, P.F.; Doherty, A.; Fensom, G.K.; Freeman, J.R.; Gorzelitz, J.S.; Jin, D.; McClain, K.M.; Papier, K.; Patel, S.; et al. Association of Accelerometer-Measured Physical Activity Level with Risks of Hospitalization for 25 Common Health Conditions in UK Adults. JAMA Netw. Open 2023, 6, e2256186. [Google Scholar] [CrossRef]
  274. Hooker, S.P.; Diaz, K.M.; Blair, S.N.; Colabianchi, N.; Hutto, B.; McDonnell, M.N.; Vena, J.E.; Howard, V.J. Association of Accelerometer-Measured Sedentary Time and Physical Activity with Risk of Stroke Among US Adults. JAMA Netw. Open 2022, 5, e2215385. [Google Scholar] [CrossRef] [PubMed]
  275. Mandolesi, L.; Polverino, A.; Montuori, S.; Foti, F.; Ferraioli, G.; Sorrentino, P.; Sorrentino, G. Effects of Physical Exercise on Cognitive Functioning and Wellbeing: Biological and Psychological Benefits. Front. Psychol. 2018, 9, 509. [Google Scholar] [CrossRef] [PubMed]
  276. Thapa, N.; Kim, B.; Yang, J.-G.; Park, H.-J.; Jang, M.; Son, H.-E.; Kim, G.-M.; Park, H. The Relationship between Chronotype, Physical Activity and the Estimated Risk of Dementia in Community-Dwelling Older Adults. Int. J. Environ. Res. Public Health 2020, 17, 3701. [Google Scholar] [CrossRef] [PubMed]
  277. Soldan, A.; Alfini, A.; Pettigrew, C.; Faria, A.; Hou, X.; Lim, C.; Lu, H.; Spira, A.P.; Zipunnikov, V.; Albert, M.; et al. Actigraphy-estimated physical activity is associated with functional and structural brain connectivity among older adults. Neurobiol. Aging 2022, 116, 32–40. [Google Scholar] [CrossRef] [PubMed]
  278. Mahindru, A.; Patil, P.; Agrawal, V. Role of Physical Activity on Mental Health and Well-Being: A Review. Cureus 2023, 15, e33475. [Google Scholar] [CrossRef] [PubMed]
  279. Feng, H.; Yang, L.; Liang, Y.Y.; Ai, S.; Liu, Y.; Liu, Y.; Jin, X.; Lei, B.; Wang, J.; Zheng, N.; et al. Associations of timing of physical activity with all-cause and cause-specific mortality in a prospective cohort study. Nat. Commun. 2023, 14, 930. [Google Scholar] [CrossRef]
  280. Brito, L.C.; Marin, T.C.; Azevêdo, L.; Rosa-Silva, J.M.; Shea, S.A.; Thosar, S.S. Chronobiology of Exercise: Evaluating the Best Time to Exercise for Greater Cardiovascular and Metabolic Benefits. Compr. Physiol. 2022, 12, 3621–3639. [Google Scholar] [CrossRef] [PubMed]
  281. Tian, C.; Bürki, C.; Westerman, K.E.; Patel, C.J. Association between timing and consistency of physical activity and type 2 diabetes: A cohort study on participants of the UK Biobank. Diabetologia 2023, 66, 2275–2282. [Google Scholar] [CrossRef] [PubMed]
  282. Homolka, P.; Cornelissen, G.; Homolka, A.; Siegelova, J.; Halberg, F. Exercise-associated transient circadian hypertension (CHAT)? In Proceedings of the III International Conference, Civilization Diseases in the Spirit of V.I. Vernadsky, People’s Friendship University of Russia, Moscow, Russia, 10–12 October 2005; pp. 419–421. [Google Scholar]
  283. Bano-Otalora, B.; Martial, F.; Harding, C.; Bechtold, D.A.; Allen, A.E.; Brown, T.M.; Belle, M.D.C.; Lucas, R.J. Bright daytime light enhances circadian amplitude in a diurnal mammal. Proc. Natl. Acad. Sci. USA 2021, 118, e2100094118. [Google Scholar] [CrossRef] [PubMed]
  284. Münch, M.; Nowozin, C.; Regente, J.; Bes, F.; De Zeeuw, J.; Hädel, S.; Wahnschaffe, A.; Kunz, D. Blue-Enriched Morning Light as a Countermeasure to Light at the Wrong Time: Effects on Cognition, Sleepiness, Sleep, and Circadian Phase. Neuropsychobiology 2016, 74, 207–218. [Google Scholar] [CrossRef] [PubMed]
  285. Figueiro, M.G.; Sahin, L.; Kalsher, M.; Plitnick, B.; Rea, M.S. Long-Term, All-Day Exposure to Circadian-Effective Light Improves Sleep, Mood, and Behavior in Persons with Dementia. J. Alzheimer’s Dis. Rep. 2020, 4, 297–312. [Google Scholar] [CrossRef] [PubMed]
  286. Juda, M.; Liu-Ambrose, T.; Feldman, F.; Suvagau, C.; Mistlberger, R.E. Light in the Senior Home: Effects of Dynamic and Individual Light Exposure on Sleep, Cognition, and Well-Being. Clocks Sleep 2020, 2, 557–576. [Google Scholar] [CrossRef]
  287. Zang, L.; Liu, X.; Li, Y.; Liu, J.; Lu, Q.; Zhang, Y.; Meng, Q. The effect of light therapy on sleep disorders and psychobehavioral symptoms in patients with Alzheimer’s disease: A meta-analysis. PLoS ONE 2023, 18, e0293977. [Google Scholar] [CrossRef] [PubMed]
  288. Gubin, D.G.; Gubin, G.D.; Waterhouse, J.; Weinert, D. The Circadian Body Temperature Rhythm in the Elderly: Effect of Single Daily Melatonin Dosing. Chronobiol. Int. 2006, 23, 639–658. [Google Scholar] [CrossRef] [PubMed]
  289. Bazyar, H.; Javid, A.Z.; Zakerkish, M.; Yousefimanesh, H.A.; Haghighi-Zadeh, M.H. Effects of melatonin supplementation in patients with type 2 diabetes mellitus and chronic periodontitis under nonsurgical periodontal therapy: A double-blind randomized controlled trial. J. Res. Med. Sci. 2022, 27, 52. [Google Scholar] [CrossRef]
  290. Böhmer, M.N.; Oppewal, A.; Valstar, M.J.; Bindels, P.J.E.; van Someren, E.J.W.; Maes-Festen, D.A.M. Light up: An intervention study of the effect of environmental dynamic lighting on sleep–wake rhythm, mood and behaviour in older adults with intellectual disabilities. J. Intellect. Disabil. Res. 2022, 66, 756–781. [Google Scholar] [CrossRef] [PubMed]
  291. Khalsa, S.B.S.; Jewett, M.E.; Cajochen, C.; Czeisler, C.A. A Phase Response Curve to Single Bright Light Pulses in Human Subjects. J. Physiol. 2003, 549, 945–952. [Google Scholar] [CrossRef] [PubMed]
  292. Lewy, A.J.; Ahmed, S.; Jackson, J.M.L.; Sack, R.L. Melatonin Shifts Human Orcadian Rhythms According to a Phase-Response Curve. Chronobiol. Int. 1992, 9, 380–392. [Google Scholar] [CrossRef] [PubMed]
  293. Burgess, H.J.; Revell, V.L.; Molina, T.A.; Eastman, C.I. Human Phase Response Curves to Three Days of Daily Melatonin: 0.5 mg Versus 3.0 mg. J. Clin. Endocrinol. Metab. 2010, 95, 3325–3331. [Google Scholar] [CrossRef]
  294. Partonen, T. Chronotype and Health Outcomes. Curr. Sleep Med. Rep. 2015, 1, 205–211. [Google Scholar] [CrossRef]
  295. Knutson, K.L.; von Schantz, M. Associations between chronotype, morbidity and mortality in the UK Biobank cohort. Chronobiol. Int. 2018, 35, 1045–1053. [Google Scholar] [CrossRef] [PubMed]
  296. Makarem, N.; Paul, J.; Giardina, E.G.V.; Liao, M.; Aggarwal, B. Evening chronotype is associated with poor cardiovascular health and adverse health behaviors in a diverse population of women. Chronobiol. Int. 2020, 37, 673–685. [Google Scholar] [CrossRef]
  297. Baldanzi, G.; Hammar, U.; Fall, T.; Lindberg, E.; Lind, L.; Elmståhl, S.; Theorell-Haglöw, J. Evening chronotype is associated with elevated biomarkers of cardiometabolic risk in the EpiHealth cohort: A cross-sectional study. Sleep 2021, 45, zsab226. [Google Scholar] [CrossRef] [PubMed]
  298. Dowling, G.A.; Burr, R.L.; Van Someren, E.J.W.; Hubbard, E.M.; Luxenberg, J.S.; Mastick, J.; Cooper, B.A. Melatonin and Bright-Light Treatment for Rest–Activity Disruption in Institutionalized Patients with Alzheimer’s Disease. J. Am. Geriatr. Soc. 2008, 56, 239–246. [Google Scholar] [CrossRef] [PubMed]
  299. Riemersma-van der Lek, R.F.; Swaab, D.F.; Twisk, J.; Hol, E.M.; Hoogendijk, W.J.; Van Someren, E.J. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: A randomized controlled trial. JAMA 2008, 299, 2642–2655. [Google Scholar] [CrossRef]
  300. McCurry, S.M.; Pike, K.C.; Vitiello, M.V.; Logsdon, R.G.; Larson, E.B.; Teri, L. Increasing Walking and Bright Light Exposure to Improve Sleep in Community-Dwelling Persons with Alzheimer’s Disease: Results of a Randomized, Controlled Trial. J. Am. Geriatr. Soc. 2011, 59, 1393–1402. [Google Scholar] [CrossRef]
  301. Hand, A.J.; Stone, J.E.; Shen, L.; Vetter, C.; Cain, S.W.; Bei, B.; Phillips, A.J.K. Measuring light regularity: Sleep regularity is associated with regularity of light exposure in adolescents. Sleep 2023, 46, zsad001. [Google Scholar] [CrossRef] [PubMed]
  302. Wang, X.; Ma, H.; Sun, Q.; Li, J.; Heianza, Y.; Van Dam, R.M.; Hu, F.B.; Rimm, E.; Manson, J.E.; Qi, L. Coffee drinking timing and mortality in US adults. Eur. Heart J. 2025, ehae871. [Google Scholar] [CrossRef]
  303. Duncan, M.J.; Dobell, A.P.; Caygill, C.L.; Eyre, E.; Tallis, J. The effect of acute caffeine ingestion on upper body anaerobic exercise and cognitive performance. Eur. J. Sport Sci. 2018, 19, 103–111. [Google Scholar] [CrossRef]
  304. Xue, H.; Zou, Y.; Yang, Q.; Zhang, Z.; Zhang, J.; Wei, X.; Zhou, J.; Tao, X.L.; Zhang, C.; Xia, Y.; et al. The association between different physical activity (PA) patterns and cardiometabolic index (CMI) in US adult population from NHANES (2007–2016). Heliyon 2024, 10, e28792. [Google Scholar] [CrossRef] [PubMed]
  305. Dai, W.; Zhang, D.; Wei, Z.; Liu, P.; Yang, Q.; Zhang, L.; Zhang, J.; Zhang, C.; Xue, H.; Xie, Z.; et al. Whether weekend warriors (WWs) achieve equivalent benefits in lipid accumulation products (LAP) reduction as other leisure-time physical activity patterns? -Results from a population-based analysis of NHANES 2007–2018. BMC Public Health 2024, 24, 1550. [Google Scholar] [CrossRef]
  306. Piarulli, A.; Bergamasco, M.; Thibaut, A.; Cologan, V.; Gosseries, O.; Laureys, S. EEG ultradian rhythmicity differences in disorders of consciousness during wakefulness. J. Neurol. 2016, 263, 1746–1760. [Google Scholar] [CrossRef] [PubMed]
  307. Goh, G.H.; Maloney, S.K.; Mark, P.J.; Blache, D. Episodic Ultradian Events—Ultradian Rhythms. Biology 2019, 8, 15. [Google Scholar] [CrossRef] [PubMed]
  308. Baria, A.T.; Baliki, M.N.; Parrish, T.; Apkarian, A.V. Anatomical and Functional Assemblies of Brain BOLD Oscillations. J. Neurosci. 2011, 31, 7910–7919. [Google Scholar] [CrossRef]
  309. Chang, C.; Metzger, C.D.; Glover, G.H.; Duyn, J.H.; Heinze, H.-J.; Walter, M. Association between heart rate variability and fluctuations in resting-state functional connectivity. NeuroImage 2013, 68, 93–104. [Google Scholar] [CrossRef] [PubMed]
  310. Chen, J.E.; Glover, G.H. BOLD fractional contribution to resting-state functional connectivity above 0.1 Hz. NeuroImage 2015, 107, 207–218. [Google Scholar] [CrossRef] [PubMed]
  311. Otsuka, K.; Cornelissen, G.; Furukawa, S.; Shibata, K.; Kubo, Y.; Mizuno, K.; Aiba, T.; Ohshima, H.; Mukai, C. Unconscious mind activates central cardiovascular network and promotes adaptation to microgravity possibly anti-aging during 1-year-long spaceflight. Sci. Rep. 2022, 12, 11862. [Google Scholar] [CrossRef] [PubMed]
  312. Otsuka, K.; Cornelissen, G.; Kubo, Y.; Shibata, K.; Mizuno, K.; Aiba, T.; Furukawa, S.; Ohshima, H.; Mukai, C. Methods for assessing change in brain plasticity at night and psychological resilience during daytime between repeated long-duration space missions. Sci. Rep. 2023, 13, 10909. [Google Scholar] [CrossRef] [PubMed]
  313. Castaneda, D.; Esparza, A.; Ghamari, M.; Soltanpur, C.; Nazeran, H. A review on wearable photoplethysmography sensors and their potential future applications in health care. Int. J. Biosens. Bioelectron. 2018, 4, 195–202. [Google Scholar] [CrossRef]
  314. Scholkmann, F.; Wolf, U. The Pulse-Respiration Quotient: A Powerful but Untapped Parameter for Modern Studies About Human Physiology and Pathophysiology. Front. Physiol. 2019, 10, 371. [Google Scholar] [CrossRef] [PubMed]
  315. Rafl, J.; Bachman, T.E.; Rafl-Huttova, V.; Walzel, S.; Rozanek, M. Commercial smartwatch with pulse oximeter detects short-time hypoxemia as well as standard medical-grade device: Validation study. Digit. Health 2022, 8, 20552076221132127. [Google Scholar] [CrossRef] [PubMed]
  316. Santos, M.; Vollam, S.; Pimentel, M.A.; Areia, C.; Young, L.; Roman, C.; Ede, J.; Piper, P.; King, E.; Harford, M.; et al. The Use of Wearable Pulse Oximeters in the Prompt Detection of Hypoxemia and During Movement: Diagnostic Accuracy Study. J. Med. Internet Res. 2022, 24, e28890. [Google Scholar] [CrossRef]
  317. Charlton, P.H.; Kyriacou, P.A.; Mant, J.; Marozas, V.; Chowienczyk, P.; Alastruey, J. Wearable Photoplethysmography for Cardiovascular Monitoring. Proc. IEEE Inst. Electr. Electron. Eng. 2022, 110, 355–381. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  318. Charlton, P.H.; Allen, J.; Bailón, R.; Baker, S.; Behar, J.A.; Chen, F.; Clifford, G.D.; Clifton, D.A.; Davies, H.J.; Ding, C.; et al. The 2023 wearable photoplethysmography roadmap. Physiol. Meas. 2023, 44, 111001. [Google Scholar] [CrossRef] [PubMed]
  319. Yeung, M.K.; Lin, J. Probing depression, schizophrenia, and other psychiatric disorders using fNIRS and the verbal fluency test: A systematic review and meta-analysis. J. Psychiatr. Res. 2021, 140, 416–435. [Google Scholar] [CrossRef] [PubMed]
  320. Nishi, R.; Fukumoto, T.; Asakawa, A. Possible effect of natural light on emotion recognition and the prefrontal cortex: A scoping review of near-infrared (NIR) spectroscopy. Adv. Clin. Exp. Med. 2023, 32, 1441–1451. [Google Scholar] [CrossRef] [PubMed]
  321. Pereira, J.; Direito, B.; Lührs, M.; Castelo-Branco, M.; Sousa, T. Multimodal assessment of the spatial correspondence between fNIRS and fMRI hemodynamic responses in motor tasks. Sci. Rep. 2023, 13, 2244. [Google Scholar] [CrossRef] [PubMed]
  322. Scarapicchia, V.; Brown, C.; Mayo, C.; Gawryluk, J.R. Functional Magnetic Resonance Imaging and Functional Near-Infrared Spectroscopy: Insights from Combined Recording Studies. Front. Hum. Neurosci. 2017, 11, 419. [Google Scholar] [CrossRef] [PubMed]
  323. Orban, C.; Kong, R.; Li, J.; Chee, M.W.L.; Yeo, B.T.T. Time of day is associated with paradoxical reductions in global signal fluctuation and functional connectivity. PLoS Biol. 2020, 18, e3000602. [Google Scholar] [CrossRef]
  324. Murata, E.M.; Pritschet, L.; Grotzinger, H.; Taylor, C.M.; Jacobs, E.G. Circadian rhythms tied to changes in brain morphology in a densely-sampled male. bioRxiv 2024. [Google Scholar] [CrossRef] [PubMed]
  325. Brothers, M.C.; DeBrosse, M.; Grigsby, C.C.; Naik, R.R.; Hussain, S.M.; Heikenfeld, J.; Kim, S.S. Achievements and Challenges for Real-Time Sensing of Analytes in Sweat within Wearable Platforms. Acc. Chem. Res. 2019, 52, 297–306. [Google Scholar] [CrossRef] [PubMed]
  326. Jagannath, B.; Lin, K.-C.; Pali, M.; Sankhala, D.; Muthukumar, S.; Prasad, S. A Sweat-based Wearable Enabling Technology for Real-time Monitoring of IL-1β and CRP as Potential Markers for Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2020, 26, 1533–1542. [Google Scholar] [CrossRef] [PubMed]
  327. Hirten, R.P.; Lin, K.-C.; Whang, J.; Shahub, S.; Churcher, N.K.; Helmus, D.; Muthukumar, S.; Sands, B.; Prasad, S. Longitudinal monitoring of IL-6 and CRP in inflammatory bowel disease using IBD-AWARE. Biosens. Bioelectron. X 2024, 16, 100435. [Google Scholar] [CrossRef] [PubMed]
  328. Liu, D.; Liu, Z.; Feng, S.; Gao, Z.; Chen, R.; Cai, G.; Bian, S. Wearable Microfluidic Sweat Chip for Detection of Sweat Glucose and pH in Long-Distance Running Exercise. Biosensors 2023, 13, 157. [Google Scholar] [CrossRef] [PubMed]
  329. Ok, J.; Park, S.; Jung, Y.H.; Kim, T. Wearable and Implantable Cortisol-Sensing Electronics for Stress Monitoring. Adv. Mater. 2023, 36, e2211595. [Google Scholar] [CrossRef] [PubMed]
  330. Watkins, Z.; McHenry, A.; Heikenfeld, J. Wearing the Lab: Advances and Challenges in Skin-Interfaced Systems for Continuous Biochemical Sensing. Adv. Biochem. Eng. Biotechnol. 2024, 187, 223–282. [Google Scholar] [CrossRef]
  331. Zhang, S.; He, Z.; Zhao, W.; Liu, C.; Zhou, S.; Ibrahim, O.O.; Wang, C.; Wang, Q. Innovative Material-Based Wearable Non-Invasive Electrochemical Sweat Sensors towards Biomedical Applications. Nanomaterials 2024, 14, 857. [Google Scholar] [CrossRef] [PubMed]
  332. Singh, N.K.; Chung, S.; Chang, A.-Y.; Wang, J.; Hall, D.A. A non-invasive wearable stress patch for real-time cortisol monitoring using a pseudoknot-assisted aptamer. Biosens. Bioelectron. 2023, 227, 115097. [Google Scholar] [CrossRef] [PubMed]
  333. Ding, H.; Yang, H.; Tsujimura, S. Nature-Inspired Superhydrophilic Biosponge as Structural Beneficial Platform for Sweating Analysis Patch. Adv. Sci. 2024, 11, e2401947. [Google Scholar] [CrossRef]
  334. Brown, T.M. Melanopic illuminance defines the magnitude of human circadian light responses under a wide range of conditions. J. Pineal Res. 2020, 69, e12655. [Google Scholar] [CrossRef] [PubMed]
  335. van Duijnhoven, J.; Hartmeyer, S.; Didikoğlu, A.; Stefani, O.; Houser, K.; Kalavally, V.; Spitschan, M. Overview of wearable light loggers: State-of-the-art and outlook. TechRxiv 2024. [Google Scholar] [CrossRef]
  336. Giménez, M.C.; Stefani, O.; Cajochen, C.; Lang, D.; Deuring, G.; Schlangen, L.J.M. Predicting melatonin suppression by light in humans: Unifying photoreceptor-based equivalent daylight illuminances, spectral composition, timing and duration of light exposure. J. Pineal Res. 2022, 72, e12786. [Google Scholar] [CrossRef] [PubMed]
  337. Trinh, V.Q.; Bodrogi, P.; Khanh, T.Q. Determination and Measurement of Melanopic Equivalent Daylight (D65) Illuminance (mEDI) in the Context of Smart and Integrative Lighting. Sensors 2023, 23, 5000. [Google Scholar] [CrossRef] [PubMed]
  338. Stampfli, J.; Schrader, B.; di Battista, C.; Häfliger, R.; Schälli, O.; Wichmann, G.; Zumbühl, C.; Blattner, P.; Cajochen, C.; Lazar, R.; et al. The Light-Dosimeter: A new device to help advance research on the non-visual responses to light. Light. Res. Technol. 2023, 55, 474–486. [Google Scholar] [CrossRef] [PubMed]
  339. Juzeniene, A.; Moan, J. Beneficial effects of UV radiation other than via vitamin D production. Dermato-Endocrinology 2012, 4, 109–117. [Google Scholar] [CrossRef] [PubMed]
  340. Giménez, M.C.; Luxwolda, M.; Van Stipriaan, E.G.; Bollen, P.P.; Hoekman, R.L.; Koopmans, M.A.; Arany, P.R.; Krames, M.R.; Berends, A.C.; Hut, R.A.; et al. Effects of Near-Infrared Light on Well-Being and Health in Human Subjects with Mild Sleep-Related Complaints: A Double-Blind, Randomized, Placebo-Controlled Study. Biology 2022, 12, 60. [Google Scholar] [CrossRef] [PubMed]
  341. Li, H.; Cui, F.; Wang, T.; Wang, W.; Zhang, D. The impact of sunlight exposure on brain structural markers in the UK Biobank. Sci. Rep. 2024, 14, 10313. [Google Scholar] [CrossRef]
  342. Slominski, R.M.; Chen, J.Y.; Raman, C.; Slominski, A.T. Photo-neuro-immuno-endocrinology: How the ultraviolet radiation regulates the body, brain, and immune system. Proc. Natl. Acad. Sci. USA 2024, 121, e2308374121. [Google Scholar] [CrossRef]
  343. Kallioğlu, M.A.; Sharma, A.; Kallioğlu, A.; Kumar, S.; Khargotra, R.; Singh, T. UV index-based model for predicting synthesis of (pre-)vitamin D3 in the mediterranean basin. Sci. Rep. 2024, 14, 3541. [Google Scholar] [CrossRef] [PubMed]
  344. Hacker, E.; Horsham, C.; Allen, M.; Nathan, A.; Lowe, J.; Janda, M. Capturing Ultraviolet Radiation Exposure and Physical Activity: Feasibility Study and Comparison Between Self-Reports, Mobile Apps, Dosimeters, and Accelerometers. JMIR Res. Protoc. 2018, 7, e102. [Google Scholar] [CrossRef] [PubMed]
  345. Kervezee, L.; Dashti, H.S.; Pilz, L.K.; Skarke, C.; Ruben, M.D. Using routinely collected clinical data for circadian medicine: A review of opportunities and challenges. PLoS Digit. Health 2024, 3, e0000511. [Google Scholar] [CrossRef] [PubMed]
  346. Spitschan, M.; Zauner, J.; Tengelin, M.N.; Bouroussis, C.A.; Caspar, P.; Eloi, F. Illuminating the future of wearable light metrology: Overview of the MeLiDos Project. Measurement 2024, 235, 114909. [Google Scholar] [CrossRef]
  347. Spitschan, M. Selecting, implementing and evaluating control and placebo conditions in light therapy and light-based interventions. Ann. Med. 2024, 56, 2298875. [Google Scholar] [CrossRef]
  348. Bowman, C.; Huang, Y.; Walch, O.J.; Fang, Y.; Frank, E.; Tyler, J.; Mayer, C.; Stockbridge, C.; Goldstein, C.; Sen, S.; et al. A method for characterizing daily physiology from widely used wearables. Cell Rep. Methods 2021, 1, 100058. [Google Scholar] [CrossRef] [PubMed]
  349. Buekers, J.; Theunis, J.; De Boever, P.; Vaes, A.W.; Koopman, M.; Janssen, E.V.; Wouters, E.F.; Spruit, M.A.; Aerts, J.-M. Wearable Finger Pulse Oximetry for Continuous Oxygen Saturation Measurements During Daily Home Routines of Patients with Chronic Obstructive Pulmonary Disease (COPD) Over One Week: Observational Study. JMIR mHealth uHealth 2019, 7, e12866. [Google Scholar] [CrossRef] [PubMed]
  350. Hua, J.; Li, J.; Jiang, Y.; Xie, S.; Shi, Y.; Pan, L. Skin-Attachable Sensors for Biomedical Applications. Biomed. Mater. Devices 2022, 1, 256–268. [Google Scholar] [CrossRef]
  351. You, Y.; Liu, J.; Li, X.; Wang, P.; Liu, R.; Ma, X. Relationship between accelerometer-measured sleep duration and Stroop performance: A functional near-infrared spectroscopy study among young adults. PeerJ 2024, 12, e17057. [Google Scholar] [CrossRef] [PubMed]
  352. Emish, M.; Young, S.D. Remote Wearable Neuroimaging Devices for Health Monitoring and Neurophenotyping: A Scoping Review. Biomimetics 2024, 9, 237. [Google Scholar] [CrossRef]
  353. Huang, Y.; Mayer, C.; Walch, O.J.; Bowman, C.; Sen, S.; Goldstein, C.; Tyler, J.; Forger, D.B. Distinct Circadian Assessments from Wearable Data Reveal Social Distancing Promoted Internal Desynchrony Between Circadian Markers. Front. Digit. Health 2021, 3, 727504. [Google Scholar] [CrossRef] [PubMed]
  354. Braund, T.A.; Zin, M.T.; Boonstra, T.W.; Wong, Q.J.J.; Larsen, M.E.; Christensen, H.; Tillman, G.; O’dea, B. Smartphone Sensor Data for Identifying and Monitoring Symptoms of Mood Disorders: A Longitudinal Observational Study. JMIR Ment. Health 2022, 9, e35549. [Google Scholar] [CrossRef] [PubMed]
  355. Wu, C.; McMahon, M.; Fritz, H.; Schnyer, D.M. circadian rhythms are not captured equal: Exploring Circadian metrics extracted by differentcomputational methods from smartphone accelerometer and GPS sensors in daily life tracking. Digit. Health 2022, 8, 20552076221114201. [Google Scholar] [CrossRef]
  356. Chuang, H.H.; Lin, C.; Lee, L.A.; Chang, H.C.; She, G.J.; Lin, Y.H. Comparing Human-Smartphone Interactions and Actigraphy Measurements for Circadian Rhythm Stability and Adiposity: Algorithm Development and Validation Study. J. Med. Internet. Res. 2024, 26, e50149. [Google Scholar] [CrossRef]
  357. Innominato, P.F.; Macdonald, J.H.; Saxton, W.; Longshaw, L.; Granger, R.; Naja, I.; Allocca, C.; Edwards, R.; Rasheed, S.; Folkvord, F.; et al. Digital Remote Monitoring Using an mHealth Solution for Survivors of Cancer: Protocol for a Pilot Observational Study. JMIR Res. Protoc. 2024, 13, e52957. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Wearables available and schematics for the most typical circadian deviations. Left: Available monitoring technologies: actigraphy tracked variables (framed): activity, wrist temperature, wrist or hip light exposure; other wearables tracked variables: near-eye light dosimeters (Lidos), blood pressure, heart rate, photoplethysmography (PPG)s, biochemical variables (cortisol, interleukin-1β and C-reactive protein). Right: schematic markers of circadian disruptions: (a) deviation of average value; (b) changes in the duration of periods of activity, sleep, daylight exposure, etc.; (c) phase deviations; (d) decrease in amplitude; (e) changes in optimal parameters within the time epoch (example of light exposure); suboptimal circadian light hygiene implies deficit of daytime light and (or) excess of light at night, that can be gauged as areas outside the curve of recommendations for optimal 24 h light hygiene; see Figures 2 and 3 for further details).
Figure 1. Wearables available and schematics for the most typical circadian deviations. Left: Available monitoring technologies: actigraphy tracked variables (framed): activity, wrist temperature, wrist or hip light exposure; other wearables tracked variables: near-eye light dosimeters (Lidos), blood pressure, heart rate, photoplethysmography (PPG)s, biochemical variables (cortisol, interleukin-1β and C-reactive protein). Right: schematic markers of circadian disruptions: (a) deviation of average value; (b) changes in the duration of periods of activity, sleep, daylight exposure, etc.; (c) phase deviations; (d) decrease in amplitude; (e) changes in optimal parameters within the time epoch (example of light exposure); suboptimal circadian light hygiene implies deficit of daytime light and (or) excess of light at night, that can be gauged as areas outside the curve of recommendations for optimal 24 h light hygiene; see Figures 2 and 3 for further details).
Diagnostics 15 00327 g001
Figure 2. Examples of cases with relatively high (left) and low (right) motor activity with about 2-fold MESOR and almost 3-fold amplitude differences, while acrophases are similar. (A) 7-day actograms; (B) average 24 h patterns, (C) average 7-day patterns with approximated best-fitted 24 h cosine function with its parameters. PIM—activity data processed using proportional integration mode, a measure of activity level or vigor of motion [41].
Figure 2. Examples of cases with relatively high (left) and low (right) motor activity with about 2-fold MESOR and almost 3-fold amplitude differences, while acrophases are similar. (A) 7-day actograms; (B) average 24 h patterns, (C) average 7-day patterns with approximated best-fitted 24 h cosine function with its parameters. PIM—activity data processed using proportional integration mode, a measure of activity level or vigor of motion [41].
Diagnostics 15 00327 g002
Figure 3. Examples of light hygiene measures: (A) 24 h average patterns of blue light exposure in patients with poor (left) and fair (right) circadian light hygiene; (B) normalized circadian amplitude of light exposure (NAbl) of individuals with poor (NAbl = 0.7, left) and fair (NAbl = 1.52, right) circadian light hygiene; and (C) geometric indices of cumulative daylight deficit and nocturnal light excess [53], our reference curve modification, based on recommendations for light exposure [69], left: individual with poor circadian light hygiene (DDIbl = 473 NEIbl = 13.38); right: individual with fair light hygiene (DDIbl = 397 NEIbl = 0.17). DDIbl—Daylight Deficit Index for blue light exposure (green areas—area under the curve of recommended daylight); NEIbl—Nocturnal Excess Index of blue light exposure (black areas—area above the curve of recommended nocturnal light).
Figure 3. Examples of light hygiene measures: (A) 24 h average patterns of blue light exposure in patients with poor (left) and fair (right) circadian light hygiene; (B) normalized circadian amplitude of light exposure (NAbl) of individuals with poor (NAbl = 0.7, left) and fair (NAbl = 1.52, right) circadian light hygiene; and (C) geometric indices of cumulative daylight deficit and nocturnal light excess [53], our reference curve modification, based on recommendations for light exposure [69], left: individual with poor circadian light hygiene (DDIbl = 473 NEIbl = 13.38); right: individual with fair light hygiene (DDIbl = 397 NEIbl = 0.17). DDIbl—Daylight Deficit Index for blue light exposure (green areas—area under the curve of recommended daylight); NEIbl—Nocturnal Excess Index of blue light exposure (black areas—area above the curve of recommended nocturnal light).
Diagnostics 15 00327 g003
Table 1. Wearables for circadian medicine/chronomedicine.
Table 1. Wearables for circadian medicine/chronomedicine.
Accelerometry-Based:Others:
Actigraphs: usually wrist-worn or hip-worn devices that track movement to estimate sleep patterns over extended periods, some can also measure physical activity, skin and ambient temperature, and light exposure. Issues to resolve: lack of unified standards for quality of minimal sampling requirements, light sensors are distant from organ of vision and can be covered by clothes. Poor precision in assessment of sleep latency.Heart Rate Monitors: can be used as stand-alone devices or integrated into other wearables, offering data on heart rate variability, which can correlate with cardiovascular health, stress and sleep quality. Limitation: highly variable and depends on various external and internal factors.
Sleep Trackers: specialized watches and bands that monitor sleep stages, and overall sleep quality. Merit: can be used more widely than professional devices. Issues include inconsistent and limited accuracy across devices, as well as reduced reliability when compared to professional actigraphs.Blood Pressure Monitors: Blood pressure monitors can be utilized in chronomedicine to track 24 h changes in blood pressure throughout the day and night and how these changes vary from day to day. Limitation: regarded obtrusive by most users, interfere with quality of sleep.
Smart Watches: commercially available devices that come with built-in features to track physical activity. Merit: can be used more widely than professional devices. Issues include inconsistent and limited accuracy across devices, as well as reduced reliability when compared to professional actigraphs.Continuous Glucose Monitors (CGMs): while not exclusively for circadian research, CGMs can provide data on metabolic changes throughout the day and night. From the viewpoint of diabetes research, glucose variability is now considered as important a biomarker as the A1c. Sensitive to meal regimens and contents, which can be both limitation and merit depending on purpose of research. However, CGMs are invaluable for health in patients with diabetes.
Fitness Trackers: similar to smartwatches, these devices track steps, activity, heart rate, all of which can be relevant to circadian rhythms. Merit: can be used more widely than professional devices. Issues include inconsistent and limited accuracy across devices, as well as reduced reliability when compared to professional actigraphs.Photopletysmography (PPG) Monitors: PPG monitors can be used to measure changes in blood volume in the body, providing valuable data on heart rate variability and respiration rate. By analyzing these metrics over a 24 h period, healthcare providers can gain insight into an individual’s circadian rhythm and identify any deviations or abnormalities that may be indicative of increased risk of disease. Benefits: cost-effective, user-friendly, non-invasive, real-time monitoring of cardiovascular metrics. Limitations: sensitivity to motion artifacts, variability in accuracy based on skin characteristics.
Smart Rings: devices like the Oura Ring track sleep, temperature, and activity, and light providing insights into 24 h rhythms. Merits and issues are overall similar to smart watches and fitness trackers. Can be regarded as more convenient by some users. Light sensors are less dependent on clothes, while depend on gloves in location with low ambient temperature.Wearables for Monitoring Biochemicals: wearables that can monitor biochemicals such as C-reactive protein, interleukin-1b, and cortisol can provide important information on inflammation levels, immune system function, and stress levels throughout the day and night. By tracking these biochemical markers over time, healthcare providers can better understand how individuals’ circadian rhythm may be influencing their overall health and make informed treatment decisions. Merits: offers unique opportunity to monitor biochemicals and gene expression providing unprecedented personalized insight into non-invasive health tracking. Limitations: newly evolving field, which encounters challenges of data accuracy, interpretation, privacy concerns, and the complexities of obtaining necessary approvals and compliance with health regulations.
Footnote: Each accelerometry-based device can contribute to a better understanding of circadian rhythms and their effect on health, though it is important to note that not all are validated for research purposes to the same extent as actigraphy.
Table 2. Most common forms of circadian disruptions: typical and alternative features.
Table 2. Most common forms of circadian disruptions: typical and alternative features.
Circadian Disruption MarkerTypical DeviationAlternatives/Comments
Circadian rhythm measures
Amplitude
[11,12,36,38,56,61,62,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83]
↑ Transient elevation of amplitude due to jet lag, or shift work, over-swinging functions such as blood pressure
[84,85,86,87]
PhaseDelay →
[61,72,79,80,81,82,88,89,90,91]
Both delay → or advance ← (optimal phase position is determined by circadian clock precision
[81,91,92,93]
Waveform (circadian robustness)Reduced fitness of the curve to predictable best-fitted model
[36,61,62,72]
Flexibility rather than rigidity can be useful for adaptive needs, i.e., heart rate variability
Variability measures
Fragmentation
and regularity (activity and sleep)
IV (intra-daily variability) ↑
IS (inter-daily stability) ↓
[38,51,61,62,72,74,75,77,80,94]
Can be beneficial in certain cases such as short-term adaptation requiring high vigilance [95,96]
Large inter- and intra-individual differences in the duration of sleep cycles throughout the night [46,47]
Spectral compositionExtra-circadian dissemination (ECD): ratio between circadian and non-circadian (ultradian/infradian) amplitudes ↓
[2,10,11,12,97]
Some ultradian and infradian components are built-in and beneficial for health
[47,98,99,100,101,102]
AlignmentMisalignment: disturbed phase relationship between circadian marker rhythms
[55,56,103]
Optimal phase angles may vary depending on genotype, age, light environment: season and latitude; and meal timing if peripheral rhythms’ phases are considered.
Composite markers (area under curve), AUCs; function-on-scalar regression (FOSR), etc.↑ or ↓
[53,54,63,76,104,105,106]
Optimal reference curves may depend on genotype, age, light environment: season and latitude; and meal timing if peripheral rhythms’ phases are considered.
Social jet lag
[107,108,109,110,111,112,113,114]
Largely varies with age [111] and social obligations [115], may depend on the number of actual working days per week. All these factors can modify hazards of SJL for health.
Table 3. Summary of methods for analyzing wearable device data.
Table 3. Summary of methods for analyzing wearable device data.
MethodAdvantagesDisadvantages
Moving Linear Regression ModelsEasy to implement and interpret, widely accessible.
Good agreement with questionnaires [148].
Assume linear relationships.
Non-parametric Actigraphy IndicesEffectively capture informative features of the circadian rhythms of activity and light exposure such as their extent of irregularity; less sensitive to noise in the data.Provide information on some features of the rhythm but do not quantify the shape of circadian rhythms. Interpretation can be subjective, when sleep patterns are irregular. Non-parametric analyses might overlook underlying multi-frequency patterns or relationships that parametric methods capture.
Parametric Cosinor AnalysisEffectively models periodic data and quantifies amplitude and acrophase. Optimal for oscillations that demonstrate a tied fit to the fitted model. Provides statistical tests for the presence of a rhythm and a measure of uncertainty for the estimation of its parameters, making it easier to draw conclusions about the presence and shape of rhythms.May require the consideration of multiple harmonic terms for non-sinusoidal waveforms.
Approximation-Based Least-Squares MethodsFlexible for fitting various non-linear models. Can be applied to a wide range of models, including linear, polynomial, and non-linear functions.
Effective in minimizing residuals, thus enabling a better model fit.
Can become complex to implement and interpret with intricate models.
Require advanced computational resources. Higher-order modeling overestimates amplitude when data have gaps [138].
Fourier TransformationProvides analysis of periodic components, which is effective for analysis of periodic signals to identify dominant frequencies.
Transformation of time-domain data into frequency-domain amplitudes and phases at specified frequencies simplifies the identification of cycles.
Assumption that the signal is stationary (its statistical properties do not change over time) is not always true for real-life data.
Provides complex output, which may lack physiological relevance and requires additional expertise for meaningful interpretation of the results.
Wavelet TransformationDecomposes a signal into wavelets, localized in both time and frequency. This method is useful for analyzing non-stationary signals.
Provides information on the dominant mode of variability and how it varies over time.
Requirement of choosing the appropriate wavelet for a specific application is often not straightforward and may require trial and error, and may often lack physiological relevance.
Aimed to analyze non-stationary signals, it relies on certain assumptions of signal behavior that may not hold true for physiological data from wearables, potentially leading to inaccurate conclusions.
Hilbert TransformationUseful to analyze the phase of the reference signal against the phase of the target signal and measure phase relationships between signals [147].
Can be used to decipher non-linear and non-stationary signals.
While it can be applied for non-stationary signals, this method assumes that the signal is relatively smooth and continuous.
Swift changes in the amplitude-phase domain, data gaps and noisy data limit the accuracy of the results
Artificial Neural NetworksCapable of modeling complex, non-linear relationships.
Can learn from large datasets and improve over time.
Requires large databases for training.
Often seen as a “black box,” making the interpretation of results challenging and less transparent.
Limit-Cycle Oscillator ModelsProvide a dynamic representation of circadian rhythms.
Can incorporate feedback mechanisms, adding depth to the modeling process.
Complex to implement and understand, which may deter some users.
Require advanced computational resources and expertise, making them less accessible.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gubin, D.; Weinert, D.; Stefani, O.; Otsuka, K.; Borisenkov, M.; Cornelissen, G. Wearables in Chronomedicine and Interpretation of Circadian Health. Diagnostics 2025, 15, 327. https://doi.org/10.3390/diagnostics15030327

AMA Style

Gubin D, Weinert D, Stefani O, Otsuka K, Borisenkov M, Cornelissen G. Wearables in Chronomedicine and Interpretation of Circadian Health. Diagnostics. 2025; 15(3):327. https://doi.org/10.3390/diagnostics15030327

Chicago/Turabian Style

Gubin, Denis, Dietmar Weinert, Oliver Stefani, Kuniaki Otsuka, Mikhail Borisenkov, and Germaine Cornelissen. 2025. "Wearables in Chronomedicine and Interpretation of Circadian Health" Diagnostics 15, no. 3: 327. https://doi.org/10.3390/diagnostics15030327

APA Style

Gubin, D., Weinert, D., Stefani, O., Otsuka, K., Borisenkov, M., & Cornelissen, G. (2025). Wearables in Chronomedicine and Interpretation of Circadian Health. Diagnostics, 15(3), 327. https://doi.org/10.3390/diagnostics15030327

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop